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Noncommunicable diseases (NCDs) such as cancer, cardiovascular and neurodegenerative
diseases are amongst the top leading causes of death globally. Chronic systemic inflam-
mation is inextricably linked to the onset and development of NCDs. In light of this
global disease burden, the need for affordable and portable inflammation screening and
monitoring tests is evident.
This thesis reports on the development and evaluation of a low-cost fluorescence sens-
ing device for the detection of the inflammatory marker, amyloid fibrin(ogen), in human
platelet poor plasma (PPP). The prototype employs a spectrofluorometric-based design
and raw smartphone imaging to quantify the fluorescence intensity emitted by samples of
PPP to which the amyloid-staining fluorescent marker, Amytracker630, has been added.
It has been shown that the prototype successfully excites bound Amytracker630, elimi-
nates background light, detects fluorescence within the Amytracker630 emission spectrum,
and quantifies the detected fluorescence intensity. The design is affordable, compact, light-
weight and USB-powered.
The prototype was used to test Amytracker630-stained PPP samples from colorectal can-
cer (CRC), psoriasis (PSO), and control patients. On average, the fluorescence intensity
measurements of the CRC and PSO samples were higher than that of the control sam-
ples. An analysis of variance and post-hoc test showed a significant difference between the
control and CRC group means, and also between the control and PSO group means. How-
ever, the results from further tests, in which stained reconstituted fibrinogen samples were
analysed, suggested that Amytracker630 molecules also interact with other non-amyloid
plasma molecules and possibly experience aggregation-induced fluorescence. Therefore, it
was concluded that the fluorescence emissions from the stained PPP samples could not be
attributed solely to the presence of amyloid fibrin(ogen). Certain plasma molecules, like
fibrinogen, are upregulated during inflammation. Therefore, the fluorescence-inducing in-
teraction between the Amytracker630 and such plasma molecules may have contributed




’n Lae-koste, fluoressensie-gebaseerde amiloïed fibrien(ogeen)
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Nie-aansteeklike siektes soos kanker, kardiovaskulêre, en neurodegeneratiewe siektes is
van die hoofoorsake van sterftes wêreldwyd. Kroniese sistemiese inflammasie word ge-
assosieer met die aanvang en onwikkeling van sulke nie-aansteeklike siektes. Dit is dus
duidelik dat daar ’n behoefte vir die onwikkeling van bekostigbare inflammasie toets- en
monitering-toestelle is.
Hierdie tesis lewer verslag op die ontwikkeling en evaluasie van ’n lae-koste, fluoressensie-
metingstoestel vir die opsporing van amiloïed fibrien(ogeen) - ’n inflammatoriese merker
in menslike plaatjie-vrye plasma (PVP). Die prototipe implementeer ’n fluorospektrome-
triese ontwerp en rou slimfoonafbeelding om die fluoressensie-intensiteit wat deur PVP
monsters waarby die amiloïed-spesefieke fluoresserende merker, Amytracker630, bygevoeg
is, te kwantifiseer. Dit is bevestig dat die prototipe in staat is om verbinde Amytrac-
ker630 op te wek, agtergrond lig uit te skakel, fluoressensie binne Amytracker630 se
emissie-spektrum op te tel, en die fluoressensie te kwantifiseer. Die prototipe ontwerp
is beskostigbaar, kompak en USB-aangedryf.
Die prototipe is gebruik om PVP monsters van kolorektale kanker (KRK), psoriase (PSO)
en kontrole pasiënte te toets. Die gemiddelde fluoressensiemeting vir die KRK en PSO
monsters was hoër as die gemiddelde fluoressensiemeting vir die kontrole monsters. ’n
Variasie-ontleding en post-hoc-toets het gewys dat daar ’n beduidende verskil tussen die
KRK en kontrole groepgemiddelde en ook tussen die PSO en kontrole groepgemiddelde
was. Verdere toetse waartydens gerehidreerde fibrinogeen monsters geanaliseer is, het
wel aangedui dat die Amytracker630 molekules ook met nie-amiloïede plasma-molekules
reageer en moontlik aggregasie-geïnduseerde fluoressensie produseer. Daarom is die ge-
volgtrekking gemaak dat die die fluoressensie wat deur die PVP monsters geproduseer is,
nie alleenlik as gevolg van die teenwoordigheid van amiloïed fibrien(ogeen) was nie. Ge-
durende inflammasie word sekere plasmamolekules, soos fibrinogeen, opgereguleer. Die
interaksie tussen Amytracker630 en sulke plasmamolekules sou dus bydra tot die ver-
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Between 1346 and 1350 the black plague wiped out a third of Europe’s population [1]. The
1918 flu was responsible for at least 50 million casualties, and small pox took as many as
300 million lives in the 20th century, alone [2] . Technological and scientific advances have
allowed us to gain the upper hand against history’s leading causes of death by bacterial
or viral infection. Ironically, it has also catapulted us into an age where modern lifestyle
factors have become the root of a new global health burden - noncommunicable diseases
(NDCs).
Noncommunicable diseases such as cancer, diabetes, cardiovascular, neurodegenerative
and chronic respiratory diseases are amongst the top leading causes of death globally.
In February 2020, the World Health Organisation published a report titled, Noncommu-
nicable Diseases Progress Monitor 2020 [3], in which they state that noncommunicable
diseases are responsible for more than 70% of all deaths, worldwide. The report sheds
light on the devastating economic impact of these statistics and points out that “taking
action against NCDs is therefore not only a moral imperative, it’s an economic imperative
[3]”.
It has been shown that NCDs share certain common pathophysiological mechanisms and
molecular alterations. One such common mechanism is systemic inflammation. It is
becoming increasingly evident that chronic systemic inflammation is inextricably linked
to the onset and development of NCDs [4]. Since rapid globalization and urbanization
has cultivated a modern lifestyle that is riddled with inflammatory risk-factors, it is no
wonder we have an epidemic on our hands [5]. Pollution, abnormal dietary composition,
sedentary behaviour and chronic stress are but a few of these factors that most people
are subjected to on a daily basis [6]. Managing chronic inflammation and inflammatory
risk factors is an important line of defence in the fight against non-communicable diseases.
As the global healthcare focus shifts towards preventative medicine, the demand for
point-of-care diagnostic tools grows. In light of the current global disease burden, the
need for point-of-care screening and monitoring tests for inflammatory markers is appar-
ent. Although there are standardised tests for a variety of inflammatory markers and
inflammation indicators, these tests are often expensive and time consuming. Such tests
are typically performed in pathology labs, on expensive, non-portable equipment, and are
1
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not suitable for large-scale, point-of-care population screening and monitoring. Therefore,
the development of a point-of care inflammation-detection device will transform global
healthcare. Such a device will not only play an imperative part in the early detection and
treatment of NCDs, possibly even before the disease onset, but will also serve as a way
to monitor a patient’s recovery progress.
According to the WHO, over 85% of the global number of “premature” deaths caused by
NCDs occur in middle to low-income countries [5]. This statistic calls attention to the
fact that the development of such testing and screening solutions should be affordable
and practical within both a rural and urban context.
The first step in developing such an inflammation-detection device is the identification
of the inflammatory marker for which the device will be testing. Prof. E. Pretorius and
her research group at the Stellenbosch University Department of Physiological Sciences,
have focused their research on the discovery of new inflammatory markers. They have
discovered a prevalence of anomalous amyloid fibrin(ogen) clot formation in the blood
of individuals with inflammatory conditions [7] [8]. Fluorescent markers known to stain
amyloid structures have been shown to stain these anomalous amyloid fibrin(ogen) clots.
A protein is referred to as amyloid when it has undergone a specific process of misfolding.
An in-depth discussion about amyloid fibrin(ogen) as an inflammatory marker is given in
Section 2.1.2.
Based on the research done by Pretorius et al. these amyloid fibrin(ogen) structures are
promising indicators of chronic systemic inflammation. Furthermore, the ability of these
structures to bind to amyloid-staining fluorescent dyes make them detectable through the
conduction of fluorescence assays.
This thesis discusses the development and testing of a compact, low-cost device that
uses a fluorescence-detection system to detect the presence of amyloid fibrin(ogen) clots
in samples of human platelet poor plasma (PPP). Furthermore, the thesis evaluates the
device’s effectiveness as a tool to discriminate between the PPP of healthy individuals
and individuals with an inflammatory NCD.
1.2 Objectives
The objectives of this project are rooted in the research conducted by Pretorius et al. on
the topic of anomalous amyloid fibrin(ogen) clot formation under inflammatory conditions
[7] [8]. Since this research is ongoing, it is important to specify on which assumptions this
project and it’s objectives are based. These assumptions include:
1. Circulating inflammatory molecules interact with fibrinogen and induce the forma-
tion of anomalous amyloid fibrin(ogen) clots.
2. The presence of amyloid fibrin(ogen) clots in the blood is, therefore, indicative of
an inflammatory condition.
3. Fluorescent dyes, commonly used to stain amyloid structures, stain these amyloid
fibrin(ogen) clots and do not interact with other components of human platelet poor
plasma.
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The problem-statement given in the previous section and these fundamental assumptions
inform the objectives of this project. The objectives are to:
1. develop a device that detects the presence of amyloid fibrin(ogen) in human platelet
poor plasma by implementing an in vitro, fluorecence-based assay that utilises a
fluorescent dye known for staining amyloid structures.
2. keep the design low cost, compact, modular and low-power so that it is suitable for
use in mobile and rural clinic setups.
3. investigate the relationship between the measured fluorescence signal and the in-
flammatory status of the patient.
4. evaluate the device’s effectiveness as a tool to discriminate between the PPP of
healthy individuals and individuals with inflammatory NCDs.
5. report on possible improvements and recommendations for future development.
1.3 Thesis outline
Chapter 2 is the literature review. Firstly, this chapter discusses the physiology of
inflammation, available standardised tests for inflammation and the role of amyloid fib-
rin(ogen) as an inflammatory marker. Since the device is required to perform fluorescence
assay, the rest of the literature review discusses relevant biophotonic, optical design and
imaging concepts.
Chapter 3 discusses the design and development of the device prototype. In this section
the design requirements, system overview, component selection and evaluation, final pro-
totype assembly and cost analysis are discussed.
Chapter 4 discusses the experimental methodology used to evaluate the prototype’s per-
formance as a tool to discriminate between control individuals and individuals with an
inflammatory disease.





Inflammation is an essential part of the immune system. It is a complex and highly
coordinated response to injury, infection and other harmful stimuli - a spectacular de-
fence and repair system. During an acute inflammatory response, a cascade of micro-
circulatory events is set in motion. Vascular dilation and permeability increase, leuko-
cytes (white blood cells) accumulate in the inflamed area, and a host of inflammatory
mediating molecules is released into the circulatory system [9].
Different inflammatory stimuli activate different inflammatory pathways. Microbial pro-
ducts and cell-signalling proteins called cytokines act as inflammatory mediators by acti-
vating their corresponding receptors. This protein-ligand binding in turn activates intra-
cellular signaling pathways that direct cellular response and the production of inflamma-
tory molecules [9].
Acute inflammation is localized, short-term and vital to the body’s healing process. How-
ever, when one or more of the inflammatory pathways are dysregulated, it can lead to a
prolonged inflammatory response that is damaging to the body [9]. This type of persis-
tent, low-grade inflammation has a whole-body effect and is called chronic inflammation.
It can occur for a variety of reasons, such as long-term exposure to irritants, recurring
acute inflammatory episodes, autoimmune disorders and oxidative stress [10].
Another relevant hallmark of chronic inflammation is the metabolic dysregulation of iron.
Under non-pathogenic conditions, dietary iron in the ferric state (Fe3+) is reduced to
Fe2+ by intestinal absorptive cells, transported into the bloodstream and then oxidised
to Fe3+. Free ferric ions released in plasma are bound to the protein, transferrin, and
transported throughout the body [11]. The dysregulation of iron homeostasis may lead
to the accumulation of free ferric ions in the bloodstream, which in turn produce reactive
oxygen species and oxidative stress.
Furthermore, research shows that intestinal permeability, also known as leaky gut, leads
to bacterial translocation into extraintestinal sites such as the blood stream [12]. Dor-
mant bacteria circulating in the blood may be awakened by free iron and start to shed
inflammation inducing microbial products. Lipopolysaccharide (LPS) and lipoteichoic
acids (LTA), bacterial cell wall components of gram-negative and gram-positive bacteria
4
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respectively, are prominent examples of such microbial products [13].
Chronic inflammation has been linked to a variety of noncommunicable diseases that
plague modern society - cancer, diabetes, cardiovascular diseases, obstructive pulmonary
disease and neurodegenerative diseases such as Alzheimer’s [10]. As mentioned in Chapter
1, noncommunicable diseases are the leading global cause of death, and it is becoming
increasingly evident that chronic inflammation is a common underlying cause [3].
Unlike acute inflammation, chronic inflammation often goes undetected until it is too
late. It can wage a slow and subtle war on the body for years before a person develops a
detectable inflammatory disease [14]. Managing chronic inflammation and inflammatory
risk factors is an important line of defence in the fight against noncommunicable diseases.
The ability to measure people’s chronic inflammation levels opens doors to preventative
care, treatment management, patient progress monitoring and further epidemiological
research. The following section discusses existing tests for chronic inflammation.
2.1.1 Tests for chronic inflammation
Chronic inflammation is partly characterised by the up-regulation of various molecules.
Some of these molecules are used as biomarkers in common inflammation tests. A
biomarker is a molecule that is up-regulated or down-regulated during a pathogenic pro-
cess and can therefore be used to identify a certain pathogenic state [15].
Standardised tests for chronic inflammation include the detection of biomarkers CRP,
fibrinogen, tnf-α and interleuken 1-β, 6 and 8 [10]. Plasma viscocity (PV) and erythrocyte
sedimentation rate (ESR) are also used as indicators of inflammation. These tests are not
suitable for point-of-care testing and high-volume patient screening, since they require
large and expensive equipment and technical expertise.
C-reactive protein
C-reactive protein (CRP) is an acute-phase protein produced in the liver. Acute-phase
proteins are proteins that become up-regulated or down-regulated in response to inflam-
matory cytokines. Although the concentration of acute-phase proteins also changes during
acute inflammation caused by injury or infection, it has been shown that CRP is also as-
sociated with chronic inflammation [16]. Therefore, the blood concentration of CRP is a
widely used, relatively inexpensive measure of systemic inflammation.
Standardised CRP tests are done in pathology laboratories, which means that the blood
samples have to be sent away and that the results are only made available after a few days.
These test can therefore not be used as a quick screening tool for chronic inflammation
and inflammatory disease risk cases. CRP test costs approximately R200 at Pathcare
[17].
Fibrinogen
Fibrinogen is a plasma protein that plays an important role in blood-coagulation. In the
event of an injury, fibrinogen is converted to fibrin by the enzyme thrombin. Fibrin is
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a fibrous protein that aggregates into a polymerized mesh-like structure and joins forces
with activated platelets to seal the injured area [18].
Fibrinogen is also an acute phase protein. It circulates in the bloodstream at concentra-
tions between 2 and 5 mg/ml in healthy individuals. During an inflammatory response,
the concentration of fibrinogen may exceed 7mg/ml [18]. Fibrinogen tests are also done
at pathology laboratories and they cost approximately R600 [17].
ESR, TEG and VP
The increased concentration of fibrinogen and other factors during an inflammatory re-
sponse, has an effect on the body’s hemodynamics. Erythrocyte sedimentation rate
(ESR), viscoelastic properties of blood clots, and the viscosity of blood are all examples
of hemodynamic factors that can be tested to gain insight into a person’s inflammatory
profile.
Fibrinogen is a pro-sedimentation factor, and therefore causes the erythrocyte sedimen-
tation rate to increase [19]. The ESR is measured as the rate at which red blood cells
separate from the plasma and settle at the bottom of a standardised tube. ESR tests are
also available at pathology laboratories. They are cheap, but very non-specific.
Thromboelastography (TEG) is a test that detects, quantifies and visualises the dynamic
changes of the blood’s viscoelastic properties during clotting [20]. Amongst others, propor-
ties such as the rate of clot formation, clot strength and rate of fibrinolysis are measured
and displayed on a graph called a thromboelastograph [21]. Figure 2.1 shows an example
of an thromboelastograph. TEGs can be used to detect hypercoagulability and hypofib-
rinolysis, both of which have been shown to occur during chronic systemic inflammation
[22]. However, in clinical settings, TEGs are more often used to inform haemostatic ther-
apy in bleeding patients, and not to detect systemic inflammation.
Figure 2.1: Thromboelastograph
Finally, an increase in fibrinogen also leads to an increase in plasma viscosity (PV) - a
property that can be measured using a viscometer. Viscometer prices can range from R30
000 to more than R150 000.
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TNF-α and Interleuken 1-β, 6 and 8
Tumor necrosis factor-alpha(NF-α) and Interleuken 1-β, 6 and 8 are inflammatory cy-
tokines. As discussed earlier, inflammatory cytokines are proteins that regulate and me-
diate the inflammatory response.
Interleukin-1β (IL-1) and tumor necrosis factor- (TNF) play a significant role in the func-
tional effects of Parkinson’s disease [23], while Interleukin-6 has shown to be an important
role-player in autoimmune diseases. It has been shown that people with obstructive pul-
monary disease have elevated levels of Interleuken 8 [24].
Although these markers are more specific indicators, they are tested for with the use of
expensive ELISA kits. ELISA kits cost between R4000 and R50000 and can only be used
once.
2.1.2 Amyloid fibrin(ogen) as an inflammatory marker
It has recently been reported that many chronic inflammatory diseases, such as cancer,
diabetes, psoriasis, rheumatoid arthritis and cardiovascular disease are accompanied, and
possibly aggravated by the formation of anomalous amyloid fibrin(ogen) clots in the blood
[7]. This discovery has brought these amyloid fibrin(ogen) clots into the spotlight as a
potential inflammatory marker. The term fibrin(ogen) is used to simultaneously refer to
both fibrinogen and fibrin, since the anomalous protein misfolding is observed both in
circulating fibrinogen and the fibrin networks of clots.
This section discusses the mechanism of protein amyloid formation and the roll that
certain microbial products and inflammatory markers play in the formation of anomalous
amyloid fibrin(ogen) clots.
Protein amyloid formation
When proteins enter an amyloid state, they unfold into elongated fibrils that form dense,
insoluble aggregates. These extracellular amyloid deposits build up in tissue and organs,
causing a variety of diseases [25]. This section discusses the general structure of proteins
and the mechanism of amyloid formation.
The functional properties of a protein is dependant on its three-dimensional structure
[26]. A protein consists of multiple amino-acids that are linked together by peptide bonds
to form a polypeptide. An amino acid consists of a central carbon atom that is linked to
a amino group, a carboxyl group and a side chain. A peptide bond is formed when the
carboxyl group of one amino acid links with the amino group of another in a dehydration
synthesis reaction. There are twenty different types of amino acids, each with a different
side chain chemistry [27]
.
The amino acid side chains are capable of forming intramolecular bonds with each other.
Depending on the amino-acid sequence and the side-chain interactions, the polypeptide
will fold into a specific structure. This is the protein’s primary structure.
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Figure 2.2: Amino acid
Furthermore, the formation of hydrogen bonds between amino and carboxyl groups causes
the protein to fold and bend further. These folding patterns are known as alpha helices
and beta strands. They make up the secondary structure of the protein. Figure 2.3 shows
simplified illustrations of the side chain interactions as well as the alpha helix and beta
strand folding patterns [27].
Figure 2.3: Primary and secondary protein structures
Amyloid protein aggregates are formed when sequential changes in the folding process
lead to misfolded proteins [7]. These misfolded proteins settle into many-stranded beta
sheet structures that stack on each other to form amyloid fibrils [25]. The amyloid fibrils
are insoluble and aggregate to form matted deposits in tissue and organs. Figure 2.4
shows a simplified visualisation of the stacked beta-sheet amyloid structure.
Figure 2.4: Amyloid protein structure
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Amyloid fibrin(ogen) and inflammation
As discussed earlier in this section, fibrinogen and fibrin are key components of blood
clots [18]. During thrombosis, the fibrinogen protein undergoes a process called pro-
teolytic cleavage. The enzyme, thrombin, cleaves certain peptides from the fibrinogen
proteins to form fibrin monomers that quickly polymerizes into a fibrin clot [18]. When
a blood vessel wall is damaged, activated platelets and polymerized fibrin accumulate at
the injured area, forming a clot that stops the bleeding.
Prof. E. Pretorius and her research group at the Stellenbosch University Department of
Physiological Sciences have published numerous papers investigating and confirming the
presence of anomalous amyloid fibrin(ogen) clots in the blood of patient with various types
of inflammatory diseases. Figure 2.5 shows scanning electron microscope (SEM) images
of fibrin networks in platelet poor plasma (PPP) from control, diabetes and Alzheimer’s-
type dementia patients [28] [29] [30].
Figure 2.5: SEM images of control, diabetes and Alzheimer’s-type dementia fibrin net-
works [from[28] [29] [30]]
The dense, matted deposits seen in the images of the diabetes and Alzheimer’s-type de-
mentia fibrin networks were also seen in other inflammatory diseases. Pretorius et al. also
used confocal microscopy to show that the these matted deposits can be stained using
fluorescent dyes known for staining amyloid structures, thereby confirming the amyloid-
like nature of the deposits.
Pretorius et al. suggest that the presence of inflammogens and acute phase proteins in-
teract with healthy fibrinogen and initiate protein misfolding that leads to the formation
of anomalous amyloid fibrin(ogen) [28]. They have confirmed the role of LPS, LTA, SAA
and free ferric iron in amyloid fibrin formation by comparing the amyloid content of fibrin
clots formed in naive PPP with that in PPP which has been exposed to the mentioned
inflammatory markers [28] [31].
Figure 2.6 shows confocal images of clots formed in control and LTA-exposed PPP. Both
the control and LTA-exposed PPP were stained with three amyloid-staining dyes - Amy-
tracker480, Amytracker680 and ThT.
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Figure 2.6: Confocal images of stained control and LTA-exposed clots
The use of amyloid-staining fluorescent dyes and confocal microscopy has been an impera-
tive part of the research done by Pretorius et al. and has been invaluable in the detection,
analysis and identification of amyloid fibrin(ogen). This is why the specified method of
detection for this project is fluorescence-detection.
2.2 Biophotonics
Biophotonics is the science of the interaction between light and biological material. It is a
multidisciplinary field that draws upon biological, chemical, optical, medical and enginee-
ring principles. Biophotonics has become an invaluable resource in medicine and medical
research. Practical applications of biophotonic processes include noninvasive biometric
measuring techniques, biological imaging and characterization, the detection of patholo-
gical structures and conditions, light therapies and laser-based surgical procedures [32].
The interaction between light and biological material manifests in a variety of optical
phenomena. These include the reflection, refraction and scattering of the incident light,
as well as the absorption of photon energy. The basic principles of light and general
light-matter interactions are discussed in Section 2.2.1.
The absorption of light by target tissue is an important interaction utilised in many the-
rapeutic and analytical processes. Techniques such as photoablation and the induction
of thermal or photo-chemical effects are used to destroy unwanted tissue, while low light
therapy is used to stimulate tissue healing[32]. Furthermore, a material’s absorption cha-
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racteristics may reveal information about its composition, structure and behaviour [33].
An important phenomenon in the world of biological imaging and analysis is a material’s
ability to re-emit absorbed light energy in the form of photons. This process is called
fluorescence and is used in many microscopy and measurement tools.
Since this thesis reports the detection of anomalous amyloid fibrin(ogen) using a fluorescence-
based assay, this section investigates the mechanisms of fluorescence, the utilization of
fluorescence in the analysis of biological material, and finally, existing fluorometric tech-
niques used to detect amyloid fibrin(ogen). But first, a firm grasp of the basic principles
of light is required.
2.2.1 Basic principles of light
Light is electromagnetic radiation that can be perceived by the human eye. Electromag-
netic radiation is the propagation of energy in the form of oscillating electric and magnetic
fields [34]. It has a dual nature - in some instances electromagnetic radiation behaves as
a wave, and in other instances as a particle that carries a discrete quantum of electro-
magnetic energy. This particle is called a photon [32].
An electromagnetic wave is described in terms of the amplitude and wavelength of its os-
cillating electric and magnetic fields. These fields oscillate in phase and perpendicular to
each other and the direction of propagation [34]. Figure 2.7 shows a visual representation
of an electromagnetic wave.
Figure 2.7: Electromagnetic wave
The energy carried by a photon is directly proportional to the frequency (f) and inversely
proportional to the wavelength (λ) of the associated electromagnetic wave [35].
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where, h is Plank’s constant (6.626 ×10−34 J.s) and c is the speed of light in a vacuum.
The energy of a photon is measured in units of electron-volt (eV). An electron-volt is the
kinetic energy gained by an electron after being accelerated by a potential difference of 1
volt (1 eV = 1.602 × 10−19 J) [34] [35].
The electromagnetic spectrum is the continuous distribution of electromagnetic radiation
according to wavelength or frequency. Figure 2.8 shows the EM spectrum as well as the
spectral ranges of the different classifications of EM radiation. The visible light spec-
trum exists between the UV and infrared (IR) spectral ranges. Biophotonics disciplines
primarily involve EM radiation with wavelengths that range from mid-UV to mid IR -
approximately 190nm to 10µm [32].
Figure 2.8: Electromagnetic spectrum
The scientific study of UV, visible and infrared light is called optics. The field of optics
has three major branches. Each one uses a different model to describe the behaviour and
nature of light [36].
• Geometric optics describes light as rays - hypothetical lines that illustrate the
direction of light propagation.
• Physical optics describes light as electromagnetic waves.
• Quantum optics describes light as a stream of particles called photons - each
carrying a quantum of electromagnetic energy.
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These models are used to investigate the genesis, propagation and detection of light [32].
Geometric and physical optics are useful to investigate the interaction between light and
matter in terms of transmission, reflection, refraction and diffraction [36]. An optical
system utilises these interactions to direct and manipulate light through an optical path
comprising a combination of elements such as lenses, filters, mirrors and prisms. These
concepts are discussed further in the section on optical system components, Section 2.3.
Quantum optics allows us to model atomic-level interactions between light and matter,
such as absorption and emission. This allows us to generate and detect light, and to
understand phenomena like fluorescence.
2.2.2 Fluorescence
The internal energy content of atoms and molecules are quantized [37]. This means that
they can only take on discrete values of energy. The energy state of an atom refers to
the energy levels within which its electrons exist. The energy state of a molecule may
additionally refer to the vibrational or rotational energy of the molecule [32] [37]. The
discrete energy states available to atoms and molecules are specific to the type of molec-
ular or atomic species.
Under normal circumstances, atoms and molecules mainly exist in the ground state, or
the lowest energy state. They can, however, absorb energy and transition to an excited
state, or a higher energy state. The absorbed energy can either be kinetic energy from a
collision or photon energy from EM radiation [37]. A particle will typically only remain
in an excited state for a few nanoseconds before it falls back to it’s ground state. During
this transition, energy is released in the form of heat or light.
Fluorescence occurs when a molecule absorbs light at a specific wavelength and then
subsequently emits light at a longer wavelength. The Jablonski diagram (Figure 2.9) il-
lustrates the three distinct events in a fluorescence process.
1. The molecule absorbs energy from a photon and transitions to an excited state.
Since the molecule can only transition to specific discrete energy states, the absorbed
energy must be equal to the difference between the ground state energy and the
available excited state energy [37]. This explains why fluorophores can only be
excited by certain wavelengths of light. The transition from the ground state to an
excited state occurs in the order of 10-15 s [32].
2. The molecule loses some of the absorbed energy through internal conversion or
vibrational relaxation, and relaxes to a slightly lower energy level. This is called a
non-radiative transition and occurs in the order of 10-13 s [32].
3. The molecule transitions back to its ground state, emitting a photon with lower
energy than the excitation energy. This means that the emitted light has a longer
wavelength than the excitation light. The event occurs in the order of 10-9s [32].
This time interval is known as the fluorescent lifetime [37].
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Figure 2.9: Jablonski diagram
Fluorescent molecules are called fluorophores. Some biological material have intrinsic flu-
orescent properties. The fluorescence produced by these kinds of biological materials is
called autofluorescence. When a biological material has no intrinsic fluorescent proper-
ties, or a suboptimal autofluorecence spectral profile, external fluorophores can be bound
to the molecule to facilitate a fluorescence-based molecular analysis. These external flu-
orophores are known as fluorescent dyes or probes.
Fluorophores are subject to photobleaching. Photobleaching occurs when a fluorophore
undergoes photon-induced chemical and covalent alterations [38]. In the process, the
fluorophore loses its ability to fluoresce permanently. Photobleaching can be minimized
by reducing the intensity of the excitation light or minimizing the exposure time.
2.2.3 Fluorescence intensity sensing techniques
Fluorescence is a nondestructive, sensitive and versatile tool for detecting and analysing
biological matter. Fluorescence emission has several measurable parameters. The para-
meters most commonly used in biological analysis are fluorescence intensity, fluorescence
lifetime, and fluorescence anisotropy [37]. The implementation of fluorescence lifetime
and anisotropy measurements is outside the scope of this project. Therefore, this section
focuses on the mechanisms and existing implementations of fluorescence intensity sensing.
Fluorescence intensity sensing involves the excitation of a biological sample and the de-
tection of the light emitted by the targeted fluorescent components in the sample. The
intensity of the emitted light is proportional to the number op photons incident on the
detector per unit time.
The fluorescence intensity of a fluorophore is dependent on the fluorescence quantum yield
(φ) [39]. Fluorescence quantum yield is the ratio between the number of photons absorbed
by a fluorophore and the number of photons emitted as fluorescence. In more accurate
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terms, it is the ratio between the radiative rate constant (Kr) and the sum of all the
non-radiative rate constants (Knr) of an excited-state decay [37]. The quantum yield can
therefore be described as the probability that the excitation energy will dissipate through







Fluorescence intensity sensing is a popular way to detect specific biological structural
components and dynamic chemical processes. The target-specific binding of fluorescent
dyes and the unique spectral profile of tissue autofluorescence ensure high sensing speci-
ficity [32].
The most important parameters of a fluorescent assay are the absorption and emission
spectra of the target fluoreophore. These spectra determine the selection of the excita-
tion wavelengths and the spectral range of detection. Figure 2.10 shows an example of a
typical absoption and emission spectra.
Figure 2.10: Absorption and emission spectra [from [37]]
The emission spectrum is typically a shifted copy of the absorption spectrum. The dis-
tance between the absorption and emission spectra peaks is called the Stokes shift [37].
It is preferable to select fluorophores with a large Stokes shift. If the Stokes shift is too
small, the spectra will overlap, making it difficult to separate the emitted light from the
excitation light.
A small Stokes shift may also lead to the superposition of Raman scattered light on the
emission spectrum [37]. Raman scattering is an inelastic scattering phenomenon. An
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incoming photon may either transfer a small amount of energy to a molecule, or gain a
small amount of energy from a molecule before being scattered. The wavelength of the
scattered light is therefore altered. The spectral shift may cause the scattered excitation
light to overlap with the emission spectrum. This phenomenon is specifically noticeable
in low light conditions.
There is a variety of commercially available microscopy and spectroscopy techniques that
utilise fluorescence intensity sensing to analyse biological samples.
Fluorescence microscopy
Microscopy is the use of specialised optical systems and imaging techniques to view struc-
tures that cannot be seen by the naked eye. Fluorescent microscopy utilizes fluorescent
probes to image and analyse molecular processes and structures at sub-cellular resolution.
There are multiple fluorescent microscopy techniques. The effectiveness of these tech-
niques vary in terms of spatial and temporal resolution, as well as image depth and
phototoxicity [40]. This section briefly discusses and compares the basic principles of
wide-field fluorescence microscopy and laser scanning confocal microscopy. For a more
detailed discussion on optical system components, refer to Section 2.3.
Wide-field fluorescence microscopy is a widely used fluorescence imaging technique. The
basic optical setup for a wide-field fluorescence microscope includes an excitation light
source, excitation and emission filters, an objective lens, and a detection component such
as an eyepiece or camera [37] [40]. The relative simplicity of the optical system makes
wide-field fluorescence microscopy affordable and user-friendly compared to other tech-
niques. It also induces less photobleaching than methods that use focused laser light and
have lower temporal resolution, such as laser scanning microscopy [37]. Wide-field fluo-
rescent microscopy does, however, have very low axial resolution and imaging depth. In
cases where high resolution 3D imaging is required, confocal microscopy is a more suited
technique [41].
The laser scanning confocal microscope is a powerful piece of laboratory equipment. It
not only has an advanced optical system with expensive beam steering and filtering optics,
but often also provides software solutions for complex post-processing techniques. In its
most basic form, laser scanning microscopy uses a combination of collimated laser light,
dichroic filtering, scanning mirrors and an objective lens to focus the excitation beam onto
the sample [42]. The emitted light is directed through various optical lenses and filters
before it reaches the detector. A pinhole, placed in the conjugated image plane to a focus
point on the sample, performs spatial filtering by removing light that originated from
other sample focal planes [42]. This allows the microscope to perform optical sectioning
which results in images with higher axial resolution. Since a confocal microscope does
point-scanning signal collection, the temporal resolution is low and the photobleaching
effects are more prominent.
Both wide-field fluorescent microscopes and confocal microscopes have diffraction-limited
lateral resolution [32]. There are various super-resolution fluorescence microscopy tech-
niques that achieve spatial resolutions that are not limited by light diffraction. These
techniques are outside the scope of this project and are not be discussed.
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Fluorescence spectroscopy
Fluorescence spectroscopy involves the detection and analysis of the fluorescence spec-
trum emitted by fluoreophores [43]. The emission spectrum of naturally fluorescing or
dye-stained biological matter may reveal information about sample composition, molecu-
lar interactions and pathogenic conditions [44].
Two important observables in fluorecence spectroscopy is spectral intensity distribution
and fluorescence lifetime [43]. The emitted radiant intensity per unit wavelength is de-
pendent on the fluorophore concentration and the intensity of the excitation source. The
fluorescence lifetime is independent of these parameters and is typically influenced by the
local environment, such as the temperature, pH, refractive index and presence of fluores-
cence quenchers [32].
The spectrofluorometer is a key piece of lab equipment that detects the fluorescence sig-
nature of an analyte in a sample and correlates it to the analyte concentration. A basic
spectrofluormeter design includes a light source that emits a wide, and typically con-
tinuous range of wavelengths [44]. Examples include high pressure xenon arch lamps or
supercontinuum lasers. A monochromator is used both in the excitation channel to isolate
a desired excitation wavelength, and in the detection channel to isolate a desired fluo-
rescence emission wavelength [43]. The selected emitted light is finally measured using a
detector such as a photomultiplier tube or photodiodes.
Spectrofluorometers may also contain other optical components such as fliters, mirrors
and polarisers. The design depends on the types of measurements and features that the
spectrophotometer offers. Some spectrophotometers are equipped to do more advanced
measurements such as fluorescence lifetime and anisotropy detection.
2.2.4 Intrinsic fluorescence of amyloid proteins
The implementation of fluorescence sensing techniques to detect amyloid fibrin(ogen) in
plasma, requires insight into the intrinsic fluorescence properties of amyloid fibrin(ogen)
and amyloid specific stains. This section discusses the intrinsic fluorescent signature of
aggregated amyloid proteins [45]. Section 2.2.5 explores the different commercially avai-
lable amyloid-specific fluorescent stains.
Chan et al. [45] reported their findings on the development of intrinsic fluorescence du-
ring the aggregation of amyloid proteins. The fluorescent signature of the aggregates were
determined with the use of confocal microscopy and fluorescence lifetime imaging. Con-
focal images were taken using a 405 nm laser and a detection range between 450 nm and
500 nm. The fluorescence lifetime images were taken using a 450 nm excitation source,
while recording emission above 488 nm.
The study found that amyloid proteins have intrinsic fluorescence due to the electron levels
that become available during the development of cross-beta sheet aggregates. Further-
more, it was concluded that the intrinsic fluorescence signature is independent of aromatic
amino-acid residues [45]. Aromatic amino acids have aromatic side chains and are respon-
sible for protein fluorescence [46]. The fact that the presence of aromatic residues is not
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required to observe intrinsic fluorescence in amyloid aggregates, suggests that the fluores-
cence arises from energy states that are specific to cross β-sheet molecular arrangements
[45]. Cross β-sheet aggregates are characteristic of all amyloid structures.
2.2.5 Fluorescent amyloid-binding ligands
The detection of extracellular amyloid deposits has been a topic of interest since the late
1800’s. There are a variety of fluorescent molecules that bind to the generic fibrillar amy-
loid structure and are used to detect amyloidosis in histopathology sections [47]. Binding
leads to conformational changes in the fluorescent molecule, which leads to alterations of
the moelcule’s optical and luminescent properties [48].
The most commonly used fluorescent amyloid-binding ligands are Congo red and Thioflavin
T. Luminescent conjugated oligothiophene stains, trademarked under the name Amy-
tracker, have recently been developed by the Swedish company, Ebba Tech, for amyloid-
specific staining.
Thiovlavin T
Thioflavin T (ThT) is a benzothiazole fluroescent dye. It is widely used as an in vitro
amyloid-binding ligand, since it fluoresces strongly when bound to amyloid cross β-sheet
aggregates [49]. Unbound ThT in an aqueous environment has weak fluorescence with an
excitation maxima of 350 nm and a emission maxima of 440 nm. When the molecules
bind to amyloid structures, they experience conformational changes that cause them to
fluoresce strongly at higher (red-shifed) excitation and emission maxima - 440 nm and
490 nm respectively. Figure 2.11 shows the chemical structure of a ThT molecule.
Figure 2.11: Thiovlavin T molecule
The interaction and binding mechanism between ThT and amyloid structures are not
yet fully understood. However, the widely preferred theory is that ThT binds within the
hydrophobic grooves between the solvent-exposed side-chains of the amyloid fibrils. This
binding possibly provides rigidity that prevents the molecule to enter a less-radiative,
twisted state [50] [51].
It has been reported that the relation between ThT binding and fluorescence intensity
is non-linear, since the molecule is sensitive to self-quenching. Fluorescence quenching is
a process where the interaction between molecules lowers or eliminates the fluorescence
emission. In addition to its non-linear fluorescence emission, ThT also has the ability to
induce fibril compaction [52].
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Congo Red
Congo Red (CR) is a linear, amphiphilic molecule (Figure 2.12) [53]. It is a classic amyloid
dye and was, in fact, the first dye used for the diagnosis of amyloidosis [54]. In aqueous
solutions it absorbs blue and green light and has a peak absorption wavelength of 490 nm.
This property gives the dye solution a bright red colour [53].
Figure 2.12: Congo Red molecule
When CR binds to β-sheet rich amyloid fibrils, the molecules become rigid and orient
themselves parallel to the fibril axis. The conformational change causes the molecules’
peak absorbance wavelength to shift from 490 nm to 512 nm, with a shoulder peak at
540 nm. The binding also increases the optical anisotropy of the CR, which allows the
detection of apple-green birefringence under crossed polarisers [54] [53]. Birefringence is
an optical property of a substance where the refractive index of substance changes as with
the polarization and propagation direction of the light.
Although CR is a classic amyloid dye, research over the years has shown that the binding
of CR is very non-specific for amyloid identification. The binding mechanism depend on
a number of conditions including solvent type, solution composition, pH etc [54]. CR is
also very toxic.
Amytrackers
Amytrackers are trademarked luminescent conjugated oligothiophenes (LCOs) manufac-
tured by the Swedish company Ebba Biotech. In recent years LCOs have garnered atten-
tion as amyloid-binding ligands. They have proven to be useful for the identification of
a broader variety of disease-associated protein aggregates than the classic amyloid stains
such as Thioflavin T and Congo Red [55] [56].
LCOs have flexible thiophene backbones that change conformation and lose rotational
freedom depending on the structures they bind to [48]. The absorption and emission
spectra of an LCO depends on the conformation of this backbone. The performance of
LCO as amyloid-specific ligands is dependent on the length of the backbone and location
of the anionic side chains along this backbone [56]. Ebba Biotech has developed a range
of LOCs that are specifically manufactured for amyloid-specificity. Since the molecules
are trademarked, the molecular structures have not been disclosed. However, Figure 2.13
shows the pentameric thiophene-based ligands from which one of the Amytracker pro-
ducts, Amytracker680, was derived [28].
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Figure 2.13: Pentameric thiophene-based ligands for amyloid binding
Ebba Biotech manufactures a range of Amytracker products with varying excitation and
emission spectra. The emission spectra of the Amytracker 480, 520, 630 and 680 are shown
in Figure 2.14. The fluorescent properties of the different Amytrackers are discussed and
compared in Section 3.3.1, where the selection of a fluorescent amyloid-binding ligand is
discussed.
Figure 2.14: Amytracker emission spectra [from Ebba website [57]]
2.3 Optical system components
In Section 2.2, the basic principles of light, and the three major branches of optics were
discussed. All three branches are applicable when investigating the components of a
fluorescent-based biosensor. Where physical and quantum optics are used to describe
the mechanisms behind biophotonics and photo-detection, geometric optics is useful to
describe the propagation of light through the optical train.
In this section the optical components of a fluorescent-based sensor are grouped and
discussed according to three different stages in the optical system. These stages are:
1. Sample excitation
2. Light propagation and manipulation between sample and detector, also referred to
as the optical assembly.
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 21
3. Detection
The aim is to investigate existing optical setups for fluorescent detection and to iden-
tify critical components. Furthermore, the components are evaluated in terms of their
affordability and practicality within a low-cost, portable device.
2.3.1 Excitation source
Section 2.2.2 described how the process of fluorescence is initiated when a fluorophore
absorbs light energy. There is a broad selection of excitation sources to choose from when
designing a biophotonics application. These include lamps, light emitting diodes and
various types of lasers [58]. Since the construction and mechanisms of photon emission
differ between these sources, so does the optical radiation output characteristics [59].
Radiometry is the science of measuring the power and geometric nature of electromag-
netic radiation [60]. In order to understand the power output characteristics of the various
commercially available excitation sources, it is important to understand basic radiometric
principles and terminology, which are given in Table 2.1.
Table 2.1: Radiometric quantities
Quantity Symbol Description Unit
Radiant flux Φ The energy radiated per unit time. W
Radiant intensity I Radiant flux per unit solid angle. W/sr
Irradiance E Radiant flux incident on a surface. W/m2
Radiance L
The radiant flux emitted or reflected
by a unit surface area (ds) into a unit
solid angle in a given direction.
W/sr.m2
A light source can be viewed as a surface area (ds) that emits or reflects radiant power
with a certain degree of directivity. Directivity is the degree to which the emitted radia-
tion is concentrated in a specific direction. The observed power density varies according
to the distance between the observer and the source, as well as the direction from which
the source is observed.
Radiant flux (Φ) is the amount of light energy radiated per unit time. This quantity
only describes the radiant power, but not the directivity of the radiation. In order to
account for the directivity, the quantity radiant intensity is used. Radiant intensity (I )
is the radiant flux density per unit solid angle that is emerging from a point in space and
propagating in a specified direction [60]. Figure 2.15 shows the geometry of a differential
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Figure 2.15: Differential solid angle
For biophotonics applications it is also important to be able to quantify the radiant power
incident on the excited sample. This measurement is called irradiance (E), and is defined





The output-characteristics of light sources are sometimes expressed in terms of photo-
metric quantities. Where radiometric quantities measure absolute power, photometric
quantities are weighted according to the wavelength-dependent sensitivity of the human
eye. The spectral sensitivity distribution of the human eye is shown in Figure 2.16 [60].
The photometric equivalent of radiant flux is luminous flux, which is measured in lumens
(lm). Similarly, the photometric equivalent of radiant intensity and irradiance is luminous
intensity and illuminance. The luminous intensity is measured in candela (cd) with one
candela being equal to one lumen per unit solid angle.
Figure 2.16: Spectral sensitivity of the human eye [from [60]]
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For optical systems that deal with a range of wavelengths, it is often necessary to describe
the above radiometric quantities as functions of wavelength. In such a case, the terms
spectral flux, spectral radiance, spectral radiant intensity and spectral irradiance are used.
The radiometric properties of a light source determine for which biophotonic applications
it is best suited. The choice of excitation source depends on the sample parameters,
the illumination strategy and microscope configuration, and the detector sensitivity [59].
The most common light sources for widefield fluorescence microscopy include mercury
and xenon arc lamps, metal halide lamps and LEDs. Lasers are also used in a variety of
applications, such as laser scanning confocal microscopy, superresolution microscopy and
certain fluorospectrometer designs.
Zeiss, a leading optical systems and optoelectronics company, provides the optical out-
put power (presented in mW/cm2) of the light sources most commonly used in widefield
fluorescence microscopy [59]. They list the irradiance of these sources at a specified focal
plane for a variety of common fluorophore filter sets. Table 2.2 shows the values provided
by Zeiss and is included here to provide a reference for typical source power outputs. Next
in this section, the most common light sources for fluorescence applications are discussed
in order to evaluate their practicality in a low-cost, low-power, compact design.











DAPI 23.0 5.6 14.5 0.70 (365nm)
CFP 79.8 25.0 76.0 26.5 (445nm)
GFP/FITC 32.8 52.8 57.5 39.2 (465nm)
TRITC 43.1 12.2 33.5 2.7 (535nm)
Texas Red 153.7 54.4 119.5 7.9 (585nm)
Arc discharge lamps
Arc discharge lamps produce light through electric discharge in ionised gas or metal va-
por. These lamps produce high radiant outputs and have broad spectral distributions that
stretch over the entire visible spectrum [61]. The most popular arc lamps for fluorescence
detection are mercury, xenon and metal halide lamps.
Mercury arc lamps have high intensity peaks over selected wavelength ranges, which
make them versatile excitation sources when used with optical filters [62]. The xenon arc
lamp has a more continuous and uniform spectral intensity distribution and is often used
for quantitative fluorescence detection [63]. Metal halide lamps have a similar spectral
intensity distribution as mercury arc lamps, save for pressure broadening of the spectral
lines and the higher radiation levels between spectral lines [64]. The spectral intensity
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distributions of the the popular HBO 100 mercury arc lamp and XBO75 xenon arc lamp
are given in Figure 2.17 as an example of the continuous spectrum produced by arc lamps.
Figure 2.17: Spectral intensity distribution of the HBO 100 and XBO 75 [from [62] [63]]
The disadvantages of these lamps, in the context of a low-cost portable device, include
the decay of intensity across the source lifetime and the production of excess heat. Arc
discharge lamps are also relatively unstable light sources and can be affected by electro-
magnetic fields and unstable power supplies. They are also more expensive, more energy
consuming, and typically larger than light emitting diodes.
LEDs
Light emitting diodes are solid-state semiconductor components that emit light through
the recombining of electron-hole pairs in doped semiconductors. LEDs typically have nar-
row emission bandwidths, and are defined by their peak wavelength. They are available
in an assortment of colours - or emission spectra - that vary across the visible light range
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as shown in Figure 2.18.
Figure 2.18: Spectral distribution for LUXEON 2835 Color LEDs [from datasheet]
In the last decade, LED technology has advanced tremendously. In the past, LEDs could
not compete with arc discharge lamps in terms of intensity, and were impractical for mi-
croscopy applications. Today, individual high-power LEDs are bright enough to be used
as effective monochromatic or polychromatic excitation sources in wide-field microscopy
applications [61]. LEDs also have superior temporal and spacial stability compared to the
arc discharge lamps, and their intensity can be controlled electronically and with precision
[65]. In the context of a low-cost portable device, LEDs are also promising in terms of
their compactness, affordability, long lifetimes and low energy consumption.
Lasers
Lasers are coherent, monochromatic light sources with highly collimated, gaussian output
beams. There are a variety of laser types, such as gas lasers, solid state lasers, optical
fiber laser and laser diodes. While the lasing mediums of these laser types differ, the basic
principle of light production is the same and results in emission spectra with one or a
few well-defined peaks [32]. Lasers are useful for high resolution imaging and are used
in applications like confocal laser scanning microscopy and super resolution fluorescent
microscopy.
Although the monochromatic laser beams can effectively and selectively excite single
flurophores, the high-power output can cause rapid photo bleaching. Furthermore, high
quality lasers are significantly more expensive, power-hungry and space-consuming than
LEDs.
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2.3.2 Optical assembly
The purpose of the optical assembly in a fluorescence detection device is to collect the
emitted fluorescence signal and guide it towards a detector while filtering out unwanted
wavelengths. As discussed in Section 2.2.3, there is a variety of fluorescence detecting
techniques and tools. The optical assemblies of these tools differ in design and complex-
ity. Section 2.2.3 briefly outlined the basic light path designs for widefield fluorescence
microscopy, confocal microscopy, and spectrofluorometry.
Keeping in mind that the objective of this project is to design an affordable and compact
device, it is important to identify the essential optical components required to collect,
guide and filter the sample fluorescence. Therefore, the basic fluorescence microscope
design in Figure 2.19 is used as a reference for an optical assembly that contains the
fundamental components for fluorescence detection.
Figure 2.19: Basic fluorescent microscope design
In Figure 2.19, light from a light source passes through a filter that only transmits wave-
lengths in the required excitation range. A dichroic filter - designed to transmit certain
wavelengths and reflect others - reflects the filtered excitation light towards the objective.
The objective guides the excitation light towards the sample, where the sample area that
falls within the objective field of view is illuminated. The objective collects the sample
fluorescence emission and focuses it on the detector. Before the emitted light reaches
the detector, it passes through the dichroic filter and an emission filter, so that only the
desired emission wavelengths are detected. The rest of this section explores the relevant
characteristics and parameters of objectives and optical filters.
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Objectives
The role of an objective is to magnify the sample area under inspection by collecting the
light from a focal plane in this area and focusing it at an image plane as shown in Figure
2.20 [66]. Objectives consist of muli-lens assemblies that direct light propagation through
the process of refraction. The complexity of objective lens assemblies vary according to
their ability to correct optical aberrations. Important objective specifications, other than
the magnification, are the numerical aperture (NA), working distance and field of view.
Figure 2.20: Example of an objective lens assembly
The numerical aperture specifies the objective’s ability to collect light and resolve fine
details in the object plane. The NA is a function of the half-angle (α) of the light cone
collected by the objective, which means that it is a function of the entrance lens diame-
ter (D) and the focal length or working distance (f ) of the objective [66]. The working
distance is the distance required between the front lens of the objective and the sample
plane for the magnified sample image to be in focus. The equation for the NA is given by
NA = nsinα ≈ D/2f (2.6)
where n is the refractive index of the medium between the sample and the objective.
Immersion oils are often used to increase the NA of an objective, since they have a higher
refractive index than air. Where air has a refractive index of 1, immersion oils typically
have a refractive index of 1.51 [66]. Figure 2.21 illustrates how a decrease in the focal
distance results in a greater NA, which in turn yields a finer image resolution.
Figure 2.21: Numerical aperture as a function of lens diameter and focal length
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The resolution of the magnified image is diffraction limited. The light collected from the
sample can be seen as having its origin in multiple point sources of light [67]. As the
light travels from the sample, through the objective, towards the detector, it is subject
to diffraction and scattering. Therefore, when the light reaches the detector, it no longer
consists of perfect point sources, but rather of broadened diffraction patterns called Airy
disks [68]. The size of the Airy disk depends on the wavelength of the imaged light, the
NA of the objective, and optical aberrations. The larger the NA of the objective, the
smaller the Airy disk. Figure 2.22 illustrates how two point source diffraction patterns
approach a diffraction limit.
Figure 2.22: Point sources approaching diffraction limit.
The limit of resolution is the smallest distance between the peaks of two Airy disks for
which the individual Airy disc patterns can still be resolved. According to the Abbe
diffraction criterion, the the minimum distance that can be resolved in the lateral plane
is represented by
r = γ/2NA (2.7)
where γ is the wavelength of the light that is being detected. An objective’s field of view
(FOV) refers to the area that is being magnified and imaged. The field of view’s size is
dependent on the objective magnification [66]. When an objective is used in conjunction
with an image sensor, the field of view can be described as
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Optical fiters
The role of the optical assembly is not only to guide light towards the detector, but also to
isolate the fluorescence emission by eliminating the excitation light and other unwanted
wavelengths. This is achieved with the use of optical filters. The two types of optical
filters most commonly used for fluorescence detection are absorptive and dichroic filters.
Both absorptive and dichroic filters selectively transmit certain portions of the optical
spectrum. The distinction between these two types of filters lies in the way they reject
unwanted light. While absorptive filters absorb unwanted wavelengths, dichroic filters
reflect them. Absorptive filters are typically placed perpendicular to the incident beam,
however, their absorption and emission properties are maintained over a wide range of
angles of incidence [69]. Conversely, dichroic filters are highly angle-sensitive and are
placed at a 45 degree angle relative to the incident light beam. Figure 2.23 illustrates
how a longpass absorptive and a longpass dichroic filter reject and transmit light.
Figure 2.23: Absorptive and dichroic filter transmission and rejection
Absorptive and dichroic filters can be divided into three categories according their trans-
mission and rejection band profiles. Longpass filters only transmit light above a certain
wavelength, while shortpass filters only transmit light below a certain wavelength [70].
Bandpass filters transmit certain spectral bands while rejecting the rest. Some of the key
filter specifications include cut-on and cut-off frequencies, slope and optical density.
The cut-on or cut-off wavelength of a filter defines the wavelength where the filter trans-
mission is 50% of its maximum. The position of the cut-on and cut-off wavelengths for
a shortpass, bandpass and longpass filter are shown in Figure 2.24. The slope of a filter
describes the bandwidth over which the transmission shifts from a low transmission (typ-
ically 10%) to a high transmission (typically 80%) [69]. Bandpass filters are also defined
by their center wavelength (CWL) and full-width-half-maximum (FWHM) parameters.
The FWHM is the spectral bandwidth between the cut-on and cut-off wavelengths, and
the CWL denotes the midpoint of the filter’s transmission bandwidth [70].
Another important filter parameter is the optical density (OD). The optical density de-
scribes the filter’s ability to reject wavelengths outside the passband of the filter [69]. The
OD is related to the percentage transmission of wavelengths outside the passband via
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The required optical density of a filter depends on the filtering application. For fluores-
cence detection applications it is important that the filter rejects all of the unwanted light,
and therefore ODs greater that 5 are typically recommended [70].
Figure 2.24: Filter pass bandwidths
Optical filters are fabricated in a variety of ways. The most affordable and least effective
types of filters are coloured glass or plastic filters. For applications that require superior
optical performance, hard coated and traditional coated filters are more suitable. A hard
coated filter consists of a single substrate, such as fused silica, with dense coatings that
optimise the transmission shape and performance [69]. These filters are very durable and
ideal for precision applications. Traditional coated filters consist of stacked absorbing,
interference and metallic layers. Although these filters are more affordable than hard
coated filters, their optical performance are limited in comparison.
2.3.3 Optical sensing
There are a variety of electronic components that utilise the photo-electric effect to convert
incident light to current. These include photodiodes, phototransistors, photomultiplier
tubes and optical detector arrays, such as charged coupled devices (CCD) and comple-
mentary metal-oxide-semiconductor devices (CMOS) .
Single-channel detectors, such as photodiodes and phototransistors can only detect a sin-
gle spectral channel at any given time. Multi-channel devices consist of two or three
dimensional arrays of single-channel detectors (pixels) and are used to detect multiple
spectral channels or multiple spatial channels for a given time sequence [32]. CCD and
CMOS sensors are examples of multi-channel devices. These sensors are widely used for
imaging, spectrophotometry and scientific measurements and are therefore the focus of
this discussion.
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Each pixel in a CCD sensor is a metal-oxide-semiconductor capacitor that builds up charge
by collecting the electrons released by the semiconductor layer as the light impinges on
the pixel [71]. After a specified illumination time, the pixel charges are shifted row by
row to the output register array where they are processed sequentially.
Where CCD sensors perform the charge to voltage conversion sequentially by an external
circuit, CMOS sensors do the conversion within each pixel. A CMOS pixel consists of a
photodiode, CMOS conversion and amplification circuitry, and a capacitor which voltage
is proportional to the incident light intensity [71]. Each pixel can be selected and read
individually via a read-out switch.
When a magnified image is digitally sampled by a pixel array, the resolution of the image
is once again limited. This resolution limit depends on the pixel size and can be calcu-
lated using the Nyquist-Shannon sampling theorem [72]. This theorem states that the
minimum sampling frequency that will preserve the underlying information of a signal,
must be double the frequency of the signal’s highest frequency component. As discussed
previously, the resolution of a magnified image is γ/2NA and therefore, the highest spatial
frequency component is 2NA/γ. To maintain the resolution of the image light incident on
the sensor, the spacial sampling frequency must be 4NA/γ, which means that the pixel
size must be less than or equal to γ/4NA.
In the past, CCD sensors have been the popular choice for high resolution imaging, since
the absence of complex pixel circuity allowed for small pixels and close pixel proximity.
CMOS sensors were preferred for rapid imaging applications, since the charge to pixel
conversion is performed in parallel [73]. Both technologies, especially CMOS sensors,
have undergone refinements aimed at minimizing limiting characteristics. Therefore, the
choice between CCD and CMOS is less apparent today.
The technological advances in CCD and CMOS imaging technology have led to the in-
creasing use of consumer cameras, and specifically smartphones, in low cost, portable
scientific applications [74]. Today’s smartphones offer high resolution and raw imaging
capabilities with wireless connectivity and versatile processing abilities. Therefore, one
of the first design decisions for this project was to use a smartphone camera as the im-
age detector. Section 2.4 discusses smartphone image capturing, image file formats, and
colour vision.
2.4 Smartphone imaging
The use of smartphones cameras as scientific tools has become an increasingly popular
topic. Over the last decade, smartphone camera technology has improved at an impres-
sive rate and today this technology is being recruited for applications like environmental
monitoring, colour science, biomedical applications, etc. [74]. Since smartphones are
widely used, compact and technologically versatile in relation to cost, the employment of
smartphones for healthcare applications may help democratise healthcare services [75].
Smartphone cameras are inherently designed to capture images that are aesthetically
pleasing to the human eye. From the spectral transmission of the image sensor, to pre-
processing and image compression algorithms, smartphone camera technology is designed
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to model the human visual experience - not to capture and present absolute spectral
and radiometric information. In order to use a smartphone camera for scientific imag-
ing purposes, it is important to understand how the light information is captured, how
spectral information is converted to colour data and how post-processing alters the image
information.
2.4.1 Image capturing and colour vision
A basic smartphone camera module consists of two major components - the camera lens
assembly and the image sensor. The lens assembly consists of multiple micro-lens elements
and has a fixed focal-length and aperture [76]. The lens is fixed to the image sensor to
form a compact digital camera module as shown in Figure 2.25. Smartphone cameras
almost universally have CMOS image sensors, since CCD technology is too expensive and
power-consuming.
Figure 2.25: Smartphone camera module
Small lens movements driven by auto-focusing algorithms enable smartphone cameras to
vary their focus distance. This allows smartphone cameras to take infinity-focused land-
scape shots as well as macro shots [76]. Infinity-focus refers to the ability to focus parallel
light rays that originate from an object far away. For a macro shot, the imaged object is
close, and the focus distance is finite. Figure 2.26 illustrates an infinity focus mode, and
how varying finite object distances require lens-movement.
Figure 2.26: Smartphone focus modes
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In order to interpret the information captured by a smartphone camera as radiometric and
spectral measurements, it is important to understand how the incident light is processed.
A CMOS sensor on its own can only detect the intensity of the light incident on each pixel,
but not the spectral distribution, and therefore not the colour. The colour detection is
facilitated by a colour filter array (CFA) and demosaicing algorithms. A CFA is a filter
grid with alternating red, green and blue pixel-sized filters [77]. A CFA is placed over
the CMOS sensor to create a pixel-grid with alternating red-, green- and blue- detecting
pixels. During post-processing, a demosaicing algorithm constructs a full-colour image
through interpolation [78]. Figure 2.27 shows a CFA filter in the Bayer configuration -
the most popular configuration for consumer cameras.
Figure 2.27: Bayer colour filter array
The spectral transmittance of the red, green and blue CFA filters is based on human
colour vision. The human eye responds to electromagnetic radiation with wavelengths
between 380 and 740 nanometers, but even though our colour perception is related to
wavelength, our eyes cannot actually detect the exact wavelengths of the incident light
[79]. Our colour perception relies on special photoreceptor cells in the retina, called cone
cells. There are three types of cone cells that each respond to a specific range of wave-
lengths. They are often referred to as L (long), M (medium) and S (short) cones. Figure
2.28 shows the spectral response curves of the L, M and S receptors.
Figure 2.28: Spectral response of short, medium and long receptors
When light is incident on the retina, each cone cell responds to the wavelengths that
falls within its spectral response bandwidth. The brain then forms a perception of colour
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according to the degree to which the L, M and S cones were stimulated respectively. This
mechanism of perceiving colour is called trichromacy and it allows us to describe colour
as the combination of three primary colour values, or tristimulus values [80]. The distri-
butions of the three primaries are called colour matching functions. The C.I.E. 1931 XYZ
colour matching functions shown in Figure 2.29 give an example of how red, green and
blue primaries can be combined to produce our perception of the visual spectrum.
Figure 2.29: C.I.E. 1931 XYZ colour matching functions
The colour filter arrays used in smartphone cameras and other consumer cameras are
based on the trichromacy and the spectral sensitivity of human vision. The spectral re-
sponse of the alternating Bayer colour pixels facilitates the detection of red, green and
blue tristimulus values. Furthermore, there are twice as many green pixels as there are
red and blue pixels in order to compensate for the spectral sensitivity of the human eye
as discussed in Section 2.3.1. Burggraaff et.al. [74] characterized the spectral response of
a variety of smartphone and consumer cameras as part of a study aimed at standardizing
spectral and radiometric calibration of consumer cameras. Although there are variations
between camera models, and manufacturers keep the specific filter designs under wraps,
Figure 2.30 shows what the typical spectral responses of a smartphone camera are.
Figure 2.30: Spectral response of iPhone SE, Phantom Pro4 and Samsung Galaxy S8
[from [74]].
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The conversion from detected spectra to numerical colour-coordinates is irreversible, since
a single colour-coordinate can map to an infinite number of wavelength-combinations.
However, the spectral response curves given in Figure 2.30 gives insight into the spectral
content of the light that is detected by red, green and blue channels of the camera sensor.
2.4.2 RAW vs JPEG image format
Once the image is captured by the CMOS sensor, the raw sensor data is processed and
saved in an image file format. The raw sensor data consists of the grayscale pixel values
which represent the intensity of the light incident on each pixel. The red-, green- and
blue-filtered pixels have grayscale values proportional to the respective amount of red,
green and blue light reaching the sensor. In order to construct a detailed colour image
from the raw data, a series of processing steps are performed.
As discussed in the previous section, the raw data undergoes demosaicing where the
colour information for each pixel is interpolated from neighboring grayscale pixel val-
ues. Furthermore, colour processing steps such as white balancing, gamma-correction
and tone-mapping are performed to ensure that the image is an acceptable representation
of the captured scene as a human would see it [81]. The camera software also performs
noise-reduction and sharpening to improve the perceived image quality. Once the image is
processed, its is typically compressed into a JPEG image format [82]. Figure 2.31 shows a
basic image processing pipeline. The processing order and algorithms may differ between
smartphone cameras.
Figure 2.31: Image pre-processing pipeline
JPEG compression is lossy, since the process discards image data to which the human eye
is not sensitive. Where most smartphone RAW images have 10- or 12-bit pixel-depths,
JPEG image have 8-bit pixel-depths [82]. Due to the image pre-processing and the JPEG
compression, much of the original RAW information is lost. Furthermore, where RAW
image pixel values have a linear response to varying light intensities, JPEG images do
not. Therefore, the use of JPEG-images for quantitative radiometric and spectral anal-
yses is not recommended [74]. RAW image format are more suitable for such applications.
There are many types of RAW image file formats, since most consumer camera brands
have their own RAW formats. However, Adobe developed a universal RAW image format
that is supported across platforms, called the Digital Negative (DNG) format. Smart-
phones that have the ability to shoot RAW typically use the DNG file format.
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A complication associated with using RAW images for scientific analysis is the mosaiced
nature of the image. Since demosiacing results in the loss of information, RAW images
can rather be treated as three independent images - each representing a red, green or blue
colour channel [74]. Figure 2.32 shows how a RAW image can be divided into the red,
green and blue colour channel images.
Figure 2.32: RAW image colour channels
2.5 Summary
The purpose of this literature review was to gain appropriate and sufficient insight into the
various fields of knowledge related to the development of a low-cost, fluorescence-based
amyloid fibrin(ogen) sensing device for systemic inflammation detection.
1. The mechanisms and consequences of systemic inflammation were discussed and an
overview of standardised inflammation biomarkers and tests was provided. There-
after, the mechanisms of amyloid formation and the role of amyloid fibrin(ogen) in
the inflammatory response were discussed. Note that the research on amyloid fib-
rin(ogen) and its utility as a novel indicator of inflammation is still new and ongoing.
The use of amyloid-staining fluorescent dyes and confocal microscopy has been the
preferred method of detection in the existing studies on amyloid fibrin(ogen). There-
fore, the specified method of detection for this project is fluorescence-detection.
2. The fields of knowledge related to fluorescence-detection were discussed next. Bio-
photonics, the basic principles of light and the process of fluorescence were reviewed.
Traditional fluorescence microscopy and spectroscopy techniques where discussed in
order to gain insights into the various mechanisms of fluorescence detection. These
insights will inform a simplified optical design for the detection of amyloid fib-
rin(ogen). The intrinsic fluorescent properties of amyloid proteins and fluorescent
amyloid-binding ligands were discussed in order to gain insight into the variety of
fluorescence probes available for the detection of amyloid structures.
3. The investigation of the various fluorescence microscopy and spectroscopy tech-
niques provided insight into the essential stages and components of fluorescence
detection. Excitation sources, optical assembly components and optical sensing
components were discussed to determine which components will be suitable for a
low-cost, low-power, compact device.
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4. After reviewing the various optical sensing components, smartphone imaging was
chosen for the detection stage. Therefore, the image capturing mechanisms and
spectral response of smartphones, as well as the various image file formats were
discussed.
The literature review will inform the design and the evaluation of the low-cost, fluorescence-
based amyloid fibrin(ogen) sensing device.
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Chapter 3
Design and Development of the FID
Prototype
In order to set the context for this chapter, the project objectives pertaining to the design
and development stage are revisited. As specified in Chapter 1, the objective of this
project is to:
1. develop a device that detects the presence of amyloid fibrin(ogen) in human platelet
poor plasma by implementing an in vitro, fluorescence-based assay that utilises a
fluorescent dye known for staining amyloid structures.
2. keep the design low cost, compact, modular and low power so that it is suitable for
use in mobile and rural clinic setups.
This chapter discusses the design and development methodology, which includes the iden-
tification of the design requirements, a high level system overview and, finally, the low level
design and component selection. For the sake of practicality, the device will henceforth
be referred to as an FID (fluorescence-based inflammation detector).
3.1 Design requirements
The design requirements are informed by project objectives as well as the target market,
target environment and the prospective use-cases for a FID prototype. The typical target
market for the FID includes medical practitioners, nurses and lab technicians working
in mobile care-units or rural clinics. The prospective use-cases for the FID are listed in
Table 3.1.
Table 3.1: Prospective use-cases for a FID
Preventative
care
Inflammatory diseases are typically preceded by undiagnosed long-
term chronic inflammation. The FID can be used as a point-of-care
screening tool in mobile clinics and medical consulting rooms. Risk
cases can be referred for further tests and treatment to prevent
disease development or progression.
38
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Reactive care
The FID may serve as an affordable point-of-care tool to moni-
tor response to treatment and recovery progress of patients with
chronic inflammation and/or inflammatory diseases.
Research The FID may be used as an affordable tool to test and analyse largesample sizes in a lab environment.
In these settings, medical and lab equipment must offer simple, quick and point of care
based solutions. The high level design requirements must take into consideration the
practical needs of the above-mentioned target market, target environment and use-cases.
The high-level design requirements are listed in Table 3.2.
Table 3.2: High level design requirements
Physical
Characteristics
• Compact and stable.
• Easy to move and transport.
• Modular design for easy maintenance and component
replacement.
Samples
• Sample size must be small enough for point of care tes-
ting.
• Accurate and repeatable sample preparation and place-
ment.
• Disposable sample holders.
Outputs
• Quantification of sample fluorescence via image process-
ing.
• Processing software must facilitate multiple sample tes-




• Battery- or USB-powered
Cost
• Low cost both in terms of cost to manufacture and cost
to use.
• Affordable to maintain and repair.
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3.2 System overview
The development of a fluorescence-based inflammation detecting device requires the appli-
cation of multi-disciplinary concepts and the synergistic integration of various hardware
and software components. As a first step, the main high-level system components of an
in vitro fluorescence-based assay and the requirements for successful integration are iden-
tified.
A fluorescence-based assay can be divided into four main processes - excitation, light
manipulation, detection and quantification. During excitation, target fluorophores in the
sample absorb incident light from an excitation source and then emit fluorescent light.
Secondly, a combination of filters and lenses guide the emitted fluorescent light toward
the detector, while filtering out the excitation light. Lastly, photo-detecting electronics
convert the incident light to an electronic signal which is analysed to quantify the fluo-
rescence intensity.
The absorption spectrum of the target fluorophore determines the emission spectrum
of the excitation source. The fluorophore emission spectrum determines the spectral
transmission of the optical assembly, and the spectral sensitivity of the photo-detecting
electronics. Finally, the nature of the detected signal determines how the signal is ana-
lysed. The design methodology is directed by the interdependence between the sample
composition, sample excitation, optical assembly components, and detection mechanism.
Figure 3.1 illustrates the high level system components of a fluorecence-based assay as
well as the dependencies between the spectral properties of these components. In order
to ensure the effective integration between the system components, system-level technical
requirements are defined in Table 3.3.
Figure 3.1: High level system components
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Table 3.3: System-level technical requirements
Fluorescent
marker
• The Stokes shift of the fluorescent marker must be large
enough so that the absorption and emission spectra do not
overlap. This ensures that the excitation light can be rejected
without attenuating the fluorescence emission.
• If other components in the sample have auto-fluorescence
properties, the emission spectrum of the fluorophore must be
distinguishable from the surrounding auto-fluorescence emis-
sions.
Excitation
• The peak emission wavelengths must match the peak absorp-
tion wavelengths of the fluorescent probe.
• The excitation source should be configured in a way that max-
imises irradiance and irradiant uniformity.
Optical
assembly
• The optical axis of the assembly components should be
aligned. The components must be positioned such that the
sample is situated at the assembly’s working distance.
• Optical filters should ideally have rejection optical densities
greater than 4.0, and high (>90%) pass band transmissions.
Detection
• The red, blue or green spectral response peaks of the sensor
colour filter array must ideally match the spectral peak of the
detected fluorescence.
• Pixel and sensor size should correspond to the desired field of
vision and image resolution.
• The camera module should provide access to raw image data.
Analysis
• Image processing software and data organisation must allow
for the automatic quantification of sample fluorescence for
varying sample and sub-sample sizes, as well as varying num-
bers of technical repeats per sub-sample.
• A statistical analysis must be performed to determine the
significance of the results.
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The system-level technical requirements specify the general criteria according to which
the components of the FID must be selected. These requirements address typical chal-
lenges associated with fluorescence detection such as the reduction of background noise,
optical aberrations, signal attenuation and artifacts. The low-level technical requirements
are further determined by the type of information that the FID must extract from the
fluorescence signal.
In Section 2.2.3 the two major types of fluorescence intensity sensing techniques were
discussed - fluorescence microscopy and fluorescence spectroscopy. Where fluorescence
microscopy aims to capture in-focus, high-resolution images of microscopic fluorescent
structures, fluorescence spectroscopy captures the spectral distribution of the detected
fluorescence.
In terms of a low-cost, compact, smartphone-based fluorescence detection device, a microscopy-
based solution poses a series of challenges. These include:
• The image resolution is limited by the smartphone pixel-size. Furthermore, the
sensor is divided into three colour channels, which means the resolution per colour
channel is reduced further.
• The quality and resolution of the image is highly influenced by optical aberrations.
Optical components that correct aberrations are typically more complex and ex-
pensive.
• In order to achieve adequate magnification the field of view must be very small.
This limits the sample-volume and therefore the amount of fluorescence signal that
can be detected.
• The sample-thickness must be close to zero as to avoid out-of-focus light from other
focal planes. Not only does this reduce the number of detectable fluorophores per
area, but it also creates challenges regarding repeatable sample placement.
While fluorescence microscopy images may provide valuable insight into molecular struc-
tures and binding mechanisms, it may not be the most practical solution for point-of-care
fluorescence quantification. A spectroscopy-based solution does not aim to maximize reso-
lution, magnification and focus, but rather to maximize the amount of sample fluorescence
within a specific bandwidth that reaches the detector.
The implementation of a spectroscopy-based solution is more affordable, allows for larger
sample sizes and sample depths, and is more practical for a point-of-care application.
Therefore, it was decided that the FID should implement a spectroscopy-based solution
by detecting the intensity of the sample fluorescence within the emission bandwidth of
the chosen amyloid-staining fluorophore.
Figure 3.2 is a conceptual representation of the selected high-level design and component
assembly. Section 3.3 discusses each of the components shown in the high-level design, as
well as the rationale behind the design, component selection and device assembly.
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Figure 3.2: High level design
3.3 System components selection
In Section 2.3, the typical components used in fluorescence intensity sensing devices were
evaluated in terms of their affordability and practicality within a low-cost, portable device.
In this section, knowledge gained in Section 2.3 is applied and the component selection
and design rationale are discussed. The discussion includes:
1. Fluorescent marker selection
2. Sample holder design
3. Excitation module design
4. Magnification and filtering
5. Detection and image processing
6. Device assembly
3.3.1 Fluorescent marker
This section discusses the selection of the fluorescent marker to be be used for the iden-
tification of amyloid fibrinogen structures. The fluorescent markers under consideration
include:
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As discussed in Section 2.2.4, amyloid structures have intrinsic fluorescent properties.
Therefore, it was considered to detect and quantify the amyloid fibrinogen autofluores-
cence, without adding and external fluorescent marker. A spectral analysis of amyloid
fibrin(ogen) clots, using confocal microscopy, showed that the amyloid fibrin(ogen) aut-
ofluorescence over a wide spectrum that overlaps with that of blood plasma. Further-
more, the exact spectral difference between normal fibrinogen and anomalous amyloid
fibrin(ogen) could not be confirmed. Therefore, it was decided that a fluorescent marker
with a narrower, more distinguishable emission spectrum should be used.
The more traditional amyloid-stains, ThT and Congo Red, were also considered as pos-
sible candidates. However, the ThT absorption and emsission spectra have a narrow
Stokes shift of about 40nm and the light used to excite bound Congo Red must be po-
larized to observe the apple-green birefringence. Furthermore, neither of these stains are
very amyloid-specific.
Eventually, it was decided to use Amytracker as the fluoroescent marker for this appli-
cation. Amytracker products consist of fluorescent conjugated oligothiophene molecules,
manufactured by Ebba Tech. They are advertised as being photo- and thermo-stable and
ideal for “reliable fluorescent staining of early, pre-fibrillar states of amyloids arising from
a variety of amyloidogenic proteins or peptides in tissues from a wide range of species
[57].” As discussed in Section 2.2.5, there are four Amytracker products. The absorption
and emission specifications for these products are given in Table 3.4
Table 3.4: Fluorescent marker absorption and emission spectra in nm





Amytracker630, henceforth referred to as Amy630, was chosen for the reasons listed below.
1. The Amy630 emission spectrum is distinguishable from that of plasma and other bio-
logical autofluorescence. Biological autofluorescence typically peaks between 480nm
and 580nm. Therefore, Amy480 and Amy520 were disqualified.
2. Amy630 has virtually no unbound fluorescence, which facilitates a high signal to
noise ratio.
3. The Stokes shift between the Amy630 emission and absorption spectra is large
enough to filter out the emission spectra comfortably.
4. The Amy630 peak emission band falls within the the peak spectral transmittance
band of the red filter in a typical colour filter array. This is not the case with
Amy680.
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Figure 3.3 shows how the peak emission of the Amy630 almost matches the peak spectral
sensitivity of a typical CFA red filter and how it is distinguishable from the peak auto-
fluorescence spectrum of PPP.
Figure 3.3: Emission spectra of plasma and Amy630
3.3.2 Sample holder
The sample holder is responsible for containing the sample and ensuring that the sam-
ple placement is accurate and repeatable. The aim of the FID design is not to capture
high-resolution, structural fluorescent images, but rather to collect the maximum amount
of fluorescent light from a relatively small sample volume. This means that the sample
depth is not limited to the optical assembly’s depth of field, and that the detection is
not limited to a singe focal plane. The sample holder must keep the sample in a fixed
position within the field of view. Two options were considered for sample-containment:
qualitative filter paper and a disposable 3D-printed sample holder with a sample well.
The qualitative filter paper was considered for its ability to contain the sample even when
the sample holder is not positioned horizontally. The proposed design for the filter-paper
sample holder is shown in Figure 3.4. However, after experimenting with this design, the
following issues were identified and the design was rejected.
• Sample placement is inconsistent and non-uniform
• The filter paper has high auto-fluorescence.
• Since the paper is white, it is very reflective and reflects the excitation light back
to the detector. As discussed in Section 3.3.4, a high-perfomance emission filter is
used to filter out the excitation light. However, the filter has an optical density of
4, which is not high enough to filter out direct, high-power light incidence.
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Figure 3.4: Sample holder with filter paper
Therefore, it was decided to use the 3D-printed sample-well design shown in Figure 3.5.
The rectangular, plastic sample holder fits into a slider that slides into the FID and
positions the sample well in the optical assembly’s field of view. The benefits of this
design include:
• Sample placement is repeatable.
• Sample area can be controlled and optimised for maximum fluorescence detection.
• The sample holder can be printed using black filament to maximise absorption and
minimise reflection.
• The sample holder is low-cost and disposable.
Figure 3.5: Sample slider and sample holder with well
Figure 3.5 shows the dimensions of the sample holder. The sample well can contain a
sample volume of 20 µl. The sample preparation and testing protocols are described in
Chapter 4. Furthermore, it was decided to make the sample-area slightly larger than the
optical assembly’s field of view to avoid the detection of edge effects at the sample edges.
Details regarding the field of view are discussed in Section 3.3.4.
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3.3.3 Excitation source
In Section 2.3.1 the most popular excitation sources for fluorescence detection applications
were discussed. From this discussion it became apparent that modern LED technology
offers various desirable features. LEDs are popular and versatile low cost lighting solution.
They are ideal for compact, low-energy, low cost applications that do not require highly
collimated, spectrally coherent or monochromatic light. Since these criteria match those
of the FID, it was decided to use LEDs for this application.
After considering multiple commercially availabe LEDs, the HLMP-CE34-Y1CDD LED
by Avago Technologies was selected. The HLMP-CE34 is a high-intensity cyan InGaN
(indium gallium nitride) LED. InGaN is known for having higher luminescence efficiency
than many other semiconductor materials used for green and blue LEDs. The HLMP-
CE34 LEDs also have well-defined spacial radiation patterns, clear caps for non-diffuse
radiation and good moisture and temperature resistance. The LED is available in a round
through hole package with a 5mm cap-diameter. Table 3.5 lists the electrical and radio-
metric characteristics as found in the HLMP-CE34 data sheet.
Table 3.5: HLMP-CE34 electrical and radiometric characteristics
Parameter Typ Units Test Conditions
Forward Voltage 3.2 V I = 20mA
Dominant
Wavelength
505 nm I = 20mA




Luminous Efficacy 326 lm/W Emitted Luminous
Power/Emitted
Radiant Power
Luminous Flux 2.1 lm I = 20mA
Max Luminous
Intensity
21 cd I = 20mA
This section first discusses the spectral and radiometric properties of the HLMP-CE34.
Thereafter, the geometric design of the FID excitation module is discussed, and finally
the LED circuitry design is given.
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Spectral and radiometric characteristics
The most important requirement for the selected LED is that its emission spectra should
match the absorption spectrum of the chosen fluorescent marker. Furthermore, the LED
emission bandwidth should be narrow enough that the excitation light can be filtered out
without attenuating the fluorescent emission too much.
As discussed in Section 3.3.1, the recommended excitation range of Amy630 is 460-514 nm.
The HLMP-CE34 has a peak wavelength of 501 nm and a spectral halfwidth of 30 nm.
The LED emission spectrum therefore matches the absorption spectrum of the Amy630
well, and has a narrow enough bandwidth to avoid an overlap with the Amy630 emission
spectrum. The spectral profile of the HLMP-CE34 is shown in Figure 3.6 and the Amy630
absorption spectrum is shown for reference.
Figure 3.6: LED emission spectrum vs Amy630 absorption
Next, the radiometric characteristics of the HLMP-CE34 LED are discussed. The LED
module design relies greatly on the optical power output and the spacial intensity dis-
tribution of the HLMP-CE34. The spatial intensity distribution is provided in the data
sheet and is shown in Figure 3.7. This pattern shows the normalised radiant intensity
of the LED with regards to the angular displacement. The angular displacement is the
angle from the LED surface normal at which the light is being viewed.
From the intensity distribution, it can be seen that the LED is an imperfect Lambertian
source with a viewing angle of 30◦. The intensity distribution of an imperfect Lambertian
source can be approximated by
I(θ) = I(0)cosm(θ) (3.1)
where, I(0) is the radiant intensity normal the source surface, which is also the maximum
radiant intensity. The value of m depends on the viewing angle of the LED as shown in
Stellenbosch University https://scholar.sun.ac.za





where the value of θ(1/2) is half the viewing angle of the LED. The value of m is calculated
as m = 19.99.
Figure 3.7: Spatial radiation pattern
The quantity of interest is the optical power incident on the sample area. This quantity
is referred to as irradiance and is measured in W/m2. The irradiance at a specific point





where φ is the angle of incidence and d is the distance from the source to the irradiated
surface. The angle of incidence is measured between the incident ray and the surface





which will be used in Section 2.1.2 to model the sample irradiance distribution. In order
to calculate the value of I(0), the maximum luminous intensity given in Table 3.5 must
be converted to radiant intensity, using the luminous efficacy. The luminous efficacy is
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given in lm/W, while the maximum luminous intensity is given in candela (cd). Since one
candela equals one lumen per unit solid angle, the conversion between luminous intensity














where, Ie is the radiant intensity, Iv is the luminous intensity and V is the luminous
efficacy. Using the maximum luminous intensity and the luminous efficacy given in Table




= 64.4 mW/sr. (3.6)
Geometric design
The geometric design of the excitation module refers to the placement and orientation of
the LEDs. The design must provide efficient radiation without relying on expensive and
space-consuming optics to guide and filter the excitation light. Therefore, preliminary
requirements for the geometric design of the excitation module are defined as follows:
• The sample must be irradiated from above so that the excitation light is not directed
towards the image sensor. In order to keep the design compact and affordable, it
is necessary to do as much excitation elimination through geometric design before
adding additional filtering components.
• The LED placement must maximise irradiance and irradiance uniformity over the
sample area within the constraints of the design.
The optical assembly components and the imaging sensor must be placed directly above
the sample with the optical axis originating at the center of the sample area. To make
place for these components, the LEDs have to irradiate the sample at an angle as shown
in Figure 3.8. This causes the irradiation-pattern to have rotational non-uniformity and
reduces the irradiance according to the Lambert’s cosine law as shown in (3.3).
Figure 3.8: Cross section of the excitation geometry
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Therefore, in the chosen design, two LEDs are placed opposite each other in order to
improve the irradiance uniformity and increase the radiant power incident on the sample
area. The chosen geometric design for the excitation source is shown in Figure 3.8. The
LEDs are angled such that the sample area receives the portion of the light that is con-
tained within approximately a 10 degree viewing angle.
When a surface is irradiated directly from above - when the LED surface and the irra-
diated surface are parallel - the viewing angle (θ) and the angle of incidence (φ) are the
same and the irradiation pattern has rotational symmetry. This is not the case for this
design where the LEDs are fixed at an angle (β) . The irradiation pattern for an angled
LED has longitudinal axis symmetry as shown in Figure 3.9, but not rotational symmetry.
Figure 3.9: LED irradiation distributions
In order to visualise of the irradiation distribution on the symmetry axis, (3.4) is used.
Figure 3.10 shows the theoretical irradiance distribution across the length of the sample
area when a single LED, on the left, is switched on. Figure 3.11 shows the theoretical
distribution when both LEDs are switched on.
When both LEDs are switched on, the irradiance reaches a theoretical maximum of 27.6
mW/cm2 and a minimum of 27.3 mW/cm2 along the symmetry axis. There is an increase
in uniformity when two LEDs are used in the given configuration compared to when a
single LED is used. Furthermore, the irradiance produced by the two LEDs falls within
an acceptable range when compared to the most popular light sources used in fluorescence
microscopy. Table 2.1 contains the irradiance levels of these light sources and is given in
Section 2.3.1.
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Figure 3.10: Distribution for the left side LED
Figure 3.11: Accumulative distribution of both LEDs
LED circuitry
The LEDs are powered using a transistor switching circuit and an Arduino Nano. Al-
though a battery would have been a sufficient power-source, the Arduino provides the
ability to modulate the LED outputs, which keeps the door open for future experimenta-
tion with fluorescence lifetime-imaging.
The transistor switching circuit causes the LED to draw current from VCC instead of the
Arduino output pin. Although the Arduino Nano will be able to provide enough current
for two LEDs, using the switching circuit is good practice and allows for practical scaling.
The transistor and resistor values were chosen such that the LED draws 20 mA, since this
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is the test condition given in the data sheet. The circuit diagram for the LED circuit and
the PCB design for the final excitation module is shown in Figure 3.12. The KTC9014S
surface mount NPN transistor for general purpose switching applications was selected.
Both the 47 Ω and 47 kΩ resistors are 1206 SMD resistors.
Figure 3.12: LED circuit and PCB Layout
3.3.4 Magnification and filtering
The optical assembly consists of magnification and emission filtering components. The
goal of the magnification component is to relay an image of the viewing area on the camera
sensor such that the image fills most of the sensor. The goal of the filtering component is
to reject the excitation light, while passing the fluorescence emission from the Amy630.
This section discusses the selection of these magnification and filtering components.
Magnification
When a smartphone is set to infinity-focus, the internal camera lens converges parallel
light rays at the lens focal point, which is where the image sensor is positioned. A basic
smartphone microscope consists of an external lens component that collects light from the
viewing area and converts the diverging light to parallel light, and the internal camera
lens that converges the parallel light at the image sensor. The most basic external lens
that can be used to create a smartphone microscope is an aspheric lens. Figure 3.13 shows
the lightpath through a smartphone microscope with a single aspheric lens.
Figure 3.13: Smartphone microscope using a single aspheric lens
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Although using a single aspheric lens is certainly desirable for a compact design, the fixed
working distance makes it impossible to adjust the focus if need be. Being able to adjust
working distance and focus is useful for prototyping. Furthermore, a single aspheric lens
introduces spherical aberrations that can be reduced with a more complex design. There-
fore, an affordable two-lens smartphone microscope with an adjustable working-distance
and field of view was selected for this design. The microscope also has a mechanical clamp
that helps to hold the smartphone in place. The clamp was incorporated in the design as
shown later in Figure 3.19. The microscope is shown in Figure 3.14.
The working distance of the microscope is set to 19.5mm, which results in a 3mm diameter
field of view. For these settings, the microscope creates a 1:1 magnification of the viewing
area on the image sensor. A 1:1 magnification implies that the image of the viewing area
spans a 3mm diameter area on the image sensor, which equates to a diameter of approx-
imately 2600 pixels. This information is used when determining the region of interest in
terms of pixel count during image processing.
Figure 3.14: Smartphone microscope
Filtering
Since the emission spectrum of the excitation source does not overlap the emission spec-
trum of Amy630, there is no need for an excitation filter. Therefore, this design only uses
a single emission filter to pass the fluorescence emission and reject the excitation light.
Since a single fluorophore is being detected, only one emission spectrum is of interest,
which means there is no concern for overlapping fluorophore signals. Therefore, a long
pass optical filter that passes all wavelengths above the highest excitation wavelength is
adequate for this application.
For this application, a high performance, 600 nm cut-on long-pass filter from Edmund
optics was selected. The filter is made from UV grade fused silica and is hard-coated to
prevent scratching. It has a cut-on slope of less than 1%, a minimum optical density of
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4 and 91% pass-band transmission. The filter is contained within a 3D printed holder
that is mounted on the smartphone microscope as shown in Figure 3.19. A visual repre-
sentation of the filter range as well as the chosen filter dimensions are given in Figure 3.15.
Figure 3.15: Optical filter dimensions
3.3.5 Detection
The accurate quantification of fluorescence intensity relies on the linearity of the sensor
output with regards to the intensity of the incident light. As discussed in Section 2.4.2,
raw image pixel values have a much better linear response to varying light intensities
compared to JPEG pixel values. The resolution of the fluorescent intensity measurement
is dependant on the sensor temporal noise, while the image quality at low light conditions
is influenced by the fixed pattern spatial noise.
For this design, a Samsung Galaxy S6 was chosen to detect and image the fluorescence
signal. The Samsung Galaxy S6 has raw-imaging capabilities and a back-illuminated
CMOS image sensor that allows for better low-light performance. The image sensor used
in the Galaxy S6 is the IMX240 from Sony. The sensor specs are listed in the Table 3.6.
Table 3.6: Samsung Galaxy S6 camera specifications
Sensor type IMX240 Sony CMOS
Effective Megapixels: 16.0
Sensor size 5312 x 2988 pixels
Approximate Pixel Pitch 1.12 microns
Color Filter Type RGB
Lens Fixed focal length and aperture
RAW imaging capabilities Yes
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Raw images are captured using the Android Camera2Raw sample app that utilizes the
Android Camera2 API. The app uses the camera’s auto-focus, auto-exposure and auto-
white balance controls, but does no further image processing or compression. When an
image is captured, the app saves a raw DNG image with a 10-bit pixel depth, as well as a
JPEG version of the image. Raw image outputs from CMOS sensors have pixel-to-pixel
variability in terms of dark current, read-out noise, shot noise, pixel bias and gain. This
variability leads to spatial and temporal image noise.
Fixed pattern noise (FPN) refers to the spatial variability in pixel outputs under uniform
illumination conditions. FPN is fixed between images taken at the same illumination
intensity and exposure-time. Under low illumination the dominant type of FPN is dark
signal non-uniformity (DSNU) which is mainly a result of dark-current variations.
The fixed pattern noise and average dark signal for the Samsung Galaxy6 camera sensor
was determined. Eighty dark exposures were taken and then averaged on a pixel-level
to eliminate the temporal noise. The average pixel value and standard deviation of the
resulting average dark image was then calculated to obtain the average dark signal and
the rms fixed pattern noise. The average dark image was used as a master-dark frame
and subtracted from the sample fluorescence images to correct the DSNU. Figure 3.16
shows the dark signal distribution of the master-dark frame. The rms FPN of the sensor
under dark conditions is 7.21 ADU (analogue to digital units).
Figure 3.16: Dark-signal distribution
When the pixel values are averaged to calculate the average incident fluorescence inten-
sity, the spatial noise is mostly averaged out. The noise that determines the measurement
resolution is the variation in the pixel average between dark images - the temporal noise.
Temporal sensor output variation under low light conditions is mainly due to read-out
noise. The measurement resolution was approximated by calculating the standard devia-
tion of the averaged pixel output per dark image. A standard deviation of 0.15 ADU was
calculated.
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3.3.6 Fluorescence intensity quantification
Once the raw image of the sample area is captured, the sample fluorescence intensity must
be quantified. For the evaluation phase of the FID, multiple control and inflammatory-
diseases samples have to be tested and statistical analyses have to be performed on the
results. The image processing software and data organisation must allow for the auto-
matic quantification of sample fluorescence for varying sample and sub-sample sizes, as
well as varying numbers of technical repeats per sub-sample. The raw DNG images are
saved according to the following naming convention:
S_SS_I.dng
where S is the sample name, comprising the population identifier and the patient number.
The population identifier specifies a group of people with a specific medical condition and
the patient number identifies the person from whom the blood sample was taken. SS
identifies the sub-sample number, since more than one sub-sample is tested per sample.
Each sub-sample is imaged multiple times to reduce the effect of image noise through av-
eraging. I refers to the image number. Figure 3.17 shows the testing pipeline for clarity.
The testing protocols are discussed further in Chapter 4.
Figure 3.17: Sample testing pipeline
A Python script was developed to process the raw images and store the fluorescence
measurements in a database format that allows for data analysis per image, per subsample,
per sample, and per condition. The script reads the raw image files in a specified directory,
converts the images to 2D numpy arrays using the rawpy library - a Python wrapper for
the C++ imraw library - and then processes the images. The following processing steps
are executed for each image:
• A master-dark image, created by averaging 80 dark exposures, is subtracted from
the image to eliminate the dark signal.
• The image is split into its red, green and blue channels according to the sensor CFA
pattern.
• The average intensity for each colour channel is calculated by averaging the pixel
values within the circular region of interest. The red colour channel is the channel of
interest, but the blue and green channel intensities are still calculated for reference.
The repeat images of each sub-sample are averaged to quantify the sub-sample’s fluores-
cence intensity. The unit used to describe pixel values, ADU (analogue to digital units),
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is also used here to describe the calculated fluorescence intensity. The sub-sample colour
channel values, as well as the sample and disease identifiers are saved in a Python Pandas
DataFrame data structure. Pandas DataFrames are two-dimensional, size mutable tabu-
lar data structures that provide a variety of data manipulation operations. An example
of a Pandas DataFrame containing the sample fluorescence results is given in Figure 3.18.
Figure 3.18: Pandas DataFrame containing sample fluorescence results
Pandas DataFrames, used in conjunction with the pingouin library, are powerful data-
analysis tools. As a last processing step, descriptive statistics, analysis of variance and
post hoc tests are calculated for the data. The statistic analysis results are discussed
further in Chapter 4.
3.4 Prototype assembly
In order to assemble the FID prototype, multiple mounting and housing components
were designed in Autodesk Inventor and 3D printed using a Makerbot Z18. The assembly
was designed to be modular and easily disassembled, yet stable and sturdy. Black PLA
filament was used to 3D print the components. The black filament was chosen for its
ability to absorb stray light and for the fact that it does not autofluoresce. The assembly
mounting and housing components, as well as their descriptions are listed in Table 3.7.
Figure 3.19 shows how all the components are assembled, while Figure 3.20 show the real
completed prototype.
Table 3.7: Assembly components
Main casing
The main casing holds the lighting rig, the microscope and the
LED electronics. It has a slot on the side where the sample
slider holding the sample holder is inserted. A sliding groove
guides the sample slider so that when the sample slider is fully
inserted, the sample is positioned within the field of view. The
casing was designed to have an L-shape for improved stability.
The foot of the casing contains the LED electronics and has
a slot for the USB power cable.
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Light Rig
The light rig mounts the LEDs at the correct angle. It is
designed to fit perfectly into the main casing so that no adhe-
sives or screws are necessary. This makes it easier to remove
and replace components.
LED holders
The LED holders fit into the light-rig as shown in Figure
3.19. The LED holders are separate from the light rig so that
different sizes LEDs can be used interchangeably.
Filter holder
The filter holder is designed so that it can be adhered to the
bottom of the microscope using an easily removable adhesive
polymer.
Smartphone mount
The smartphone mount fits onto the main casing. It has a
platform on which the smartphone rests and that positions the
smartphone while it is being held in place by the microscope
clip.
Figure 3.19: FID Assembly
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Figure 3.20: Final prototype
The final prototype is compact, light-weight and modular as required in the project objec-
tives. The prototype, excluding the smartphone, weighs approximately 250g and has the
dimensions shown Figure 3.20. Table 3.8 gives the bill of materials for the FID prototype
and Table 3.9 gives the cost per sub-sample. Sub-sample refers to a single sample holder
containing an aliquot of the sample under test.
In comparison to typical fluorescence intensity sensing and imaging equipment, the FID
prototype is affordable in terms of the cost to manufacture, as well as the cost to use.
The cost of the smartphone is excluded from the bill of materials, since the design can
be used with a variety of smartphone models - from high quality mid-range to high-end.
Most individuals or institutions already own smartphones that can be used with the FID
prototype. Further work will focus on the standardisation of smartphone requirements
and system calibration for various smartphone models.
Table 3.8: Bill of materials
Part Name Units Unit Cost (R) Total Cost (R)
Optical Filter 1 2330 2330
Microscope 1 150 150
LED 2 8.50 17
Arduino Nano 1 150 150
Resistor 6 0.30 1.80
Transistor 2 0.60 1.20
3D-printing 150g 1/g 150
TOTAL 2800
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Table 3.9: Cost per sub-sample
Part Name Units Unit Cost (R) Total Cost (R)
Amy630 0.05µl 150/µl 8.50




Evaluation of the FID Prototype
In order to set the context for this chapter, the project objectives pertaining to the
evaluation of the FID are revisited. As specified in Chapter 1, the objectives of this
project include to:
• investigate the relationship between the measured fluorescence signal and the in-
flammatory status of the patient.
• evaluate the device’s effectiveness as a tool to discriminate between the PPP of
healthy individuals and individuals with inflammatory NCDs.
• report on possible improvements and recommendations for future development.
During the evaluation phase, three main investigations were conducted in order to meet
the project objectives. Each of these investigations is discussed separately in this chapter.
The aim of these investigations, respectively, is to:
1. identify potential light sources that may cause background noise and evaluate the
FID design’s effectiveness in minimising such background noise.
2. use the FID to detect the fluorescent signal emitted by bound Amy630 in PPP
from control individuals and individuals with inflammatory conditions. Evaluate
the relationship between the measured fluorescence signal and the inflammatory
status of the patient and determine whether the device can differentiate between
healthy and diseased individuals.
3. determine whether the detected fluorescence originates exclusively from Amy630
bound to amyloid structures.
The evaluation of the FID prototype was conducted in a histology lab at Stellenbosch
Department of Physiological Sciences. Ethical clearance was obtained for this project
from the Health Research Ethics Committee (HREC) of Stellenbosch University and a
written form of informed consent was obtained from all blood donors. The ethical clear-
ance documentation is given in Appendix A.
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4.1 The elimination of background light
The specificity and sensitivity of the FID depends on its ability to eliminate noise from
background light sources and to isolate the Amy630 fluorescence signal. Potential sources
of background light and the design choices aimed at minimising these sources are given
in Table 4.1. In this section the effectiveness of the measures taken to minimise noise due
to background light is evaluated.
Table 4.1: Background light sources and the minimisation thereof
Excitation Light
The chosen fluorescent marker has a large Stokes shift and the se-
lected excitation source has a narrow bandwidth. Therefore, the
excitation spectrum does not overlap the Amy630 emission spec-
trum, and a single high-performance longpass optical filter is used
to reject the excitation light.
PPP
autofluorescence
The fluorescent marker emission, excitation source, and filtering
components were specifically chosen to operate outside the absorp-
tion and emission spectrum of PPP autofluorescence.
Unbound
fluorescence
The manufacturers of Amy680 claim that the fluorescent marker
has no unbound fluorescence.
First, the long-pass filter’s ability to reject the excitation light is evaluated. An empty
sample holder was placed in the FID and the light intensity was measured with and
without the optical filter. Figure 4.1 shows the comparison. The measured average light
intensity when the filter is removed was approximately 313 ADU. The vertical sections in
the image is the sample holder’s 3D-printed grooves. When the filter is added to the opti-
cal train, the measured intensity drops to the sensor’s dark-signal value. From the images
and numeric intensity measurements, it is clear that the filter does effectively minimise
the amount of excitation light that reaches the sensor.
Figure 4.1: Empty sample holder imaged with and without filter
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 4. EVALUATION OF THE FID PROTOTYPE 64
The next part evaluates whether the chosen excitation and detection spectra truly do
eliminate the effect of PPP autofluorescence. In order to create a reference, the setup
was temporarily modified so that the excitation and detection spectra fall within the ab-
sorption and emission spectra of PPP. The LEDs and long-pass filter were temporarily
replaced with counterparts that have the same specifications except for the LED emission
spectra and the longpass filter cut-on frequency. The 501 nm LEDs and 600 nm long-pass
filter from the original FID design were temporarily replaced with 405 nm LEDs and a
450 nm long-pass filter.
The same 20 µl unstained PPP from a control individual was tested with both the original
and temporary excitation and filter setups. Figure 4.2 shows a comparison between the
fluorescence detected by the two. The image on the left illustrates how important it is to
operate outside the absorption and emission spectra of PPP. The PPP autofluorescence
is very prominent when a 405 nm excitation source and 450 nm cut-on LP filter is used.
Other amyloid-staining fluorescent tags like the Amy680, Amy520 and ThT would have
been very difficult to detect amongst the autofluorescent background noise. The image
on the right shows that the official FID design does indeed minimise the influence of PPP
autofluorescence. The measured intensity is, once again, approximately equal to the sen-
sor dark-signal.
Figure 4.2: PPP autofluorescence for 405 nm and 501 nm excitation
Lastly, the unbound fluorescence of the Amy630 was evaluated. Some fluorophores do flu-
oresce when they are unbound, albeit to a lesser degree than when they are bound. This
is a potential source of background noise. Therefore, a sample of an unbound Amy630
dilution was tested with the FID to confirm whether Amy630 truly has no unbound flu-
orescence.
First an Amy630 working solution was prepared by diluting 4 µl Amy360 stock solution
with 76 µl PBS. An Amy630 dilution was then prepared by adding 6 µl Amy630 working
solution in 89 µl PBS. The concentration of Amy630 in PBS was made the same as the
concentration of Amy630 in the stained PPP samples as discussed in Section 4.2. Finally,
20 µl of the unbound Amy630 dilution was tested using the FID. No fluorescent signal
was detected, which confirmed that unbound Amy630 has no unbound fluorescence under
the FID’s excitation and filtering conditions.
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4.2 PPP sample tests
In this section the FID is used to detect the fluorescence signal emitted by bound Amy630
in PPP from control individuals and individuals with inflammatory conditions. The
results are evaluated to determine whether there is a significant difference between the
signal detected from these two test groups and whether the FID has the potential to
differentiate between healthy and inflamed individuals. This investigation was limited by
the following factors:
• The limited availability of blood and patient data
• Variance in the severity of patient inflammatory status within diseased groups.
• The uncertain effect of plasma molecules in the Amy630 binding process.
Firstly, the procurement and preparation of the PPP is discussed. Secondly, the protocol
for the sample preparation and testing is discussed. Lastly, the measured results are
presented and evaluated.
4.2.1 PPP procurement and preparation
Platelet poor plasma from six patients with colorectal cancer (CRC) and three individuals
with psoriasis (PSO) were obtained. Both these conditions are associated with elevated
systemic inflammation. These samples had been collected by Pretorius et al. for various




• Other chronic conditions
• Chronic medication
• Cancer stage for CRC patients
• Psoriasis severity for PSO patients
Platelet poor plasma from six healthy individuals were used as controls. Whole blood
from each control individual was collected in citrate tubes by a registered phlebotomist.
Each citrate tube was centrifuged at 3000 g for 15 min to separate the platelet poor
plasma. Aliquots of the PPP were prepared and stored at -80 degrees for future analysis.
TEG and CRP tests were performed on the control blood to verify that the individuals
were, in fact, suitable controls.
The control samples were labeled C1 to C6, the colorectal cancer samples were labeled
CRC1 to CRC6, and the psoriasis samples were labeled PSO1 to PSO3.
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4.2.2 Protocol
The PPP sample tests were performed according to the steps listed below. Research-grade
measuring pipettes were used to dispense the various quantities described in the protocol.
1. First, the Amy630 working solution was prepared by diluting 4 µl Amy630 stock
solution in 76 µl PBS. The Amy630 stock solution contains 1mg fluorescent conju-
gated oligothophene molecules per ml.
2. Amy630-stained PPP samples were prepared by adding 6 µl of the Amy630 working
solution to 89 µl PPP from each CRC, PSO and control individual.
3. From each PPP-Amy630 sample, three sub-samples of 20 µl each were placed in
three separate sample holders. Each sample holder was inserted into the device
where the sample was excited and the sample emission light was imaged three
times.
4. The images were then processed as discussed in Section 3.3.6. The fluorescence
intensity of each sub-sample was quantified by calculating the red channel measure-
ment of the triplicate images. The fluorescence intensity for each sample was then
obtained by averaging the red channel measurements of the three sub-samples.
4.2.3 Results and discussion
The PPP from the six control, six CRC and three PSO individuals were analysed ac-
cording to the protocol described previously. While it has previously been shown that
the unstained PPP produced no fluorescence, the PPP samples with added Amy630 did.
This indicates that the Amy630 molecules bind to molecular structures in the PPP and
undergo conformational changes that enable them to fluoresce. Figure 4.3 shows the
fluorescence detected for C3 and CRC3 as a visual example.
Figure 4.3: Fluorescence detected for C3 and CRC3 samples
The fluorescence measurement for each sample is plotted in Figure 4.4. Since these mea-
surements are the average of three sub-sample measurements, error bars were added to
illustrate the standard deviation within each averaged sample measurement. The bar
graph shows that the fluorescence measurements of the CRC and PSO samples were, on
average, higher than that of the control samples. The average fluorescence measurements
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for the C, CRC and PSO groups were 22.80 ADU, 28.67 ADU and 26.3 ADU respectively.
Figure 4.4: Average fluorescence intensity per sample
An Analysis of variance (ANOVA) was conducted to determine whether the variance be-
tween the C, CRC and PSO groups is smaller than the variances within the groups and
whether the differences between the group means are statistically significant. A signifi-
cance level of 0.05 was chosen and a Welch ANOVA was used, since it accounts for unequal
variances and sample sizes. A p-value of 0.01 < 0.05 was calculated, which indicates that
at least one of of the group means differ significantly. A pairwise Games-Howell post
hoc test was conducted to determine which means differ significantly. Table 4.2 lists the
calculated p-values.





The p-values show that there is a significant difference between the control and CRC
group means, and also between the control and PSO group means. There is, however, no
significant difference between the CRC and PSO group means, which is expected since
they both fall under the diseased population.
Although these results are promising, one must keep in mind that the sample sizes are
small due to limited PPP supplies. A more extensive study with larger sample sizes must
be conducted for more reliable results. Furthermore, the following concerns have to be
addressed:
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1. The variation in sample measurements within each of the three groups, as well as
the variation in sub-sample measurements for a specific sample.
2. The unexpectedly high amount of fluorescence in control samples.
Group and sub-sample variation
It is to be expected that the measurements for individuals within a population will differ,
since there are many factors that influence a person’s blood profile. These factors include
genetics, age, lifestyle, medication, etc.
Within a population of colorectal cancer patients, the individuals’ inflammatory profiles
vary according to the cancer stage, the patients’ response to treatment and other com-
plex factors. The inflammatory profile of blood taken from psoriasis patients depend on
the disease severity, disease activity, whether the patient is experiencing an inflammatory
flare at the time when the blood is drawn and whether the patient is taking any anti-
rheumatic medication. Furthermore, patients form a specific diseased population may
also have other types of medical conditions, which complicate their inflammatory profiles
even further.
The variation in sub-sample measurements for a specific sample can possibly be ascribed
to the following factors:
• The bound Amy630 may be non-uniformly distributed throughout the sample vol-
ume.
• The Amy630 might be interacting with other plasma molecules. The conformational
changes that the Amy360 molecules undergo when they bind might be inconsistent
throughout the sample.
• Variability in sample meniscus shape may cause variability in emission light refrac-
tion.
Control fluorescence
Although the control fluorescence measurements were lower than the CRC and PSO
measurements, the control fluorescence measurements were much higher than expected.
The project objectives and device design was based on the assumptions that Amy630 is
amyloid-specific and that the formation of amyloid firbin(ogen) clots is an indication of
an inflammatory condition.
According to the results reported by Pretorius et al. [8][14][28], the presence of amyloid
fibrin(ogen) clots in the PPP of healthy individuals is virtually non-existent compared to
PPP from individuals with inflammatory conditions. The fact that control measurement
were only marginally less than that of the CRC and PSO samples, raises the following
questions:
• Does Amy630 truly only bind to amyloid structures?
• If not, what type of alternative binding or conformational change is taking place?
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• Can the fluorescence detected from this alternative binding still be related to a
person’s inflammatory profile?
In an attempt to gain more insight into the structural binding of the Amy630, the sub-
samples were allowed to evaporate so that the settled particles could be observed on a
single focal plane. Figure 4.5 shows the fluorescence images of three CRC and three
control samples. The vertical lines may be a result of particles settling in and the light
reflecting off the grooves created by the 3D-printing process.
There is a significant difference between the CRC and control images. Although the
control images show less fluorescence than the CRC images, the fluorescence is still too
uniformly distributed to conclude that it exclusively originates from the anomalous and
sporadic amyloid fibrin(ogen) clots described by Pretorius et al. [8][14][28]. In order
to gain further insight into the amyloid-specificity of the detected signal, the interaction
between Amy630 and pure fibrinogen was conducted. This investigation is discussed next.
Figure 4.5: Fluorescence images of evaporated CRC and control samples
4.3 Amyloid-specificity of Amy630
The goal of this investigation was to draw more informed conclusions about the amyloid-
specificity of Amy630 by observing and comparing its interaction with normal and amy-
loid fibrinogen without the presence of other plasma molecules. The investigation was
conducted in an attempt to answer the following questions:
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1. Does Amy630 fluoresce in the presence of normal fibrinogen?
2. Is there a significant difference between the normal and amyloid fibrinogen sample
fluorescence when Amy630 is added?
3. What is the relationship between the sample fluorescence intensity and the Amy630
concentration?
4. How do the results relate to the PPP results of the previous section?
In order to conduct this investigation, increasing volumes of Amy630 working solution was
added to samples of reconstituted normal fibrinogen as well as LTA-exposed fibrinogen,
which were then tested using the FID. The aim of the LTA-exposure is to induce amyloid
formation in the fibrinogen molecules. According to Pretorius et al., substoichiometric
concentrations of LTA causes anomalous amyloid fibrin clots [28]. The sample preparation
and testing protocol as well as the results are discussed next.
4.3.1 Protocol
The following steps were executed for this investigation:
1. Reconstituted fibrinogen was sampled from a 2 mg/ml stock solution. The stock
solution had previously been prepared by reconstituting dehydrated fibrinogen with
phosphate-buffered saline.
2. An LTA-exposed fibrinogen sample was prepared by adding 10 µl LTA to 90 µl
of the 2 mg/ml fibrinogen stock solution. The exposed fibrinogen was allowed to
incubate for 30 min.
3. The Amy630 working solution was prepared by diluting 4 µl Amy630 stock solution
in 76 µl PBS.
4. Exposed and normal fibrinogen samples with increasing concentrations of Amy630
working solution were prepared. For both the exposed and normal fibrinogen, four
samples of 49 ul were stained with 1 µl, 3 µl, 9 µl and 27 µl Amy630 respectively.
5. Thereafter, the same testing procedures used to analyse the PPP samples were
followed. Three sub-samples for each of the four LTA-exposed fibrinogen samples,
and each of the four normal fibrinogen samples were tested.
4.3.2 Results and discussion
Figure 4.6 shows the fluorescent measurements of both the normal and LTA-exposed
fibrinogen for the increasing concentrations of Amy630. Figure 4.7 shows images of normal
fibrinogen with increasing concentrations of Amy630.
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Figure 4.6: Fluorescence measurements of normal and LTA-exposed fibrinogen for in-
creasing Amy630 concentrations
Figure 4.7: Normal fibrinogen with increasing Amy630 concentrations
Firstly, it is clear that the normal fibrinogen with added Amy630 does emit fluorescence.
This means that the conformational changes that the Amy630 molecules undergo in or-
der to fluoresce are not exclusively due to amyloid-binding. There is also no significant
difference between the normal and LTA-exposed fibrinogen. This could be due to the
fact that any change in fluorescence due to amyloid-bound Amy630 is inundated by the
background fluorescence.
Furthermore, the fluorescence produced by the fibrinogen sample is still significantly less
than that of PPP samples with the same Amy630 concentration. A fibrinogen concentra-
tion of 2 mg/ml falls within the range for a healthy individual, and therefore the fibrinogen
fluorescence results are comparable to the control PPP fluorescence results. The average
measurement for the control samples was 22.87 ADU, while the average measurement for
normal fibrinogen samples with the same Amy630 concentration was 8.87 ADU. There-
fore, it can be argued that the binding mechanism and emission of Amy630 is influenced
by the presence of other plasma molecules as well.
The graph shows that an exponential increase of Amy630 leads to linear increase in the
fluorescence measurement. Since the binding sites should become less as the Amy360
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increases it would be expected for the fluorescence to plateau. This raises the question
whether the increasing fluorescence is due to increased binding, or due to another type of
interaction.
This question led to the conduction of further research on the matter. Through the
research it was discovered that, while most fluorophores experience aggregation induced
quenching, some organic fluorophores experience aggregation-induced emission. Aggregation-
induced emission is a phenomenon where the fluorescent efficiency of a fluorophore in-
creases when the molecules aggregate [83] [84].
The manufacturers of the Amytracker630, Ebba Tech, where contacted directly to confirm
whether aggregation-induced emission could occur. The manufacturers said that, while
they have no experience when it comes to blood and plasma (only tissue), they suspect
that it is possible that the emission could be increased through aggregation. The lineari-
sation of the molecule when it binds to amyloid structures induces the fluorescence. The
same linearisation might occur when the molecules aggregate.
If this is the case, the question remains why the Amy630 molecules aggregate when they
are added to PPP and not when they are diluted in PBS. This suggests that there is an
interaction between the plasma molecules and the Amy630 molecules. It could be argued
that an increase in certain plasma molecules, such as fibrinogen, causes an increase in
Amy630 interaction, aggregation and emission. And since the upregulation of certain
plasma molecules, like fibrinogen, are indicative of inflammation, the inflammatory dis-
ease samples would therefore be expected to emit more fluorescence. This could explain
why the CRC and PSO samples had higher fluorescence intensity measurements on aver-
age than the control samples.
This theory does not exclude the effect of Amy630 bound to amyloid fibrin(ogen), since
any amyloid-bound Amy630 fluorescence would just have added to the overall fluores-
cence. The contribution of amyloid-bound Amy630 fluorescence to the total fluorescence
intensity could not be determined, since the signal would have been indistinguishable from
the rest of the fluorescence.
The theories presented in this section can only truly be tested and proven by doing
extensive nuclear magnetic resonance (NMR) and affinity studies. This is outside the





Following the objectives, a prototype was developed that aims to detect the presence
of the novel inflammation marker, amyloid fibrin(ogen), in human platelet poor plasma
by implementing an in vitro, fluorescence-based assay. The final prototype is capable of
detecting the fluorescence intensity emitted by samples of platelet poor plasma (PPP)
to which the amyloid-staining fluorescent marker, Amy630, has been added. The final
prototype has been shown to successfully:
• excite bound Amytracker630 molecules in 2 0µl platelet poor plasma samples, using
two high intensity 501 nm LEDs.
• filter out the excitation light with a 600 nm cut-on high-pass filter.
• magnify the sample area and relay an image of the sample light to the camera sensor
of a Samsung Galaxy S6 that is mounted on the device.
• capture raw images of the detected light using the Samsung Galaxy S6 smartphone
camera and a raw camera app that uses the Android Camera2 API.
• quantify the captured sample fluorescence intensity with a Python image processing
script.
The project objectives state that the device should be low-cost, compact, modular and
low-power, and suitable for use in mobile and rural clinic setups. The final prototype
only weighs 250 g and occupies a 123 mm×123 mm×89 mm space. In order to meet the
aforementioned objectives the following design decisions were made:
• The selected fluorescent marker has a large Stokes shift as well as absorption and
emissions spectra that are distinguishable from PPP autofluorescence. This elimi-
nates the need for multiple expensive and space-consuming optical filtering compo-
nents.
• LEDs are used for the excitation source. They are compact, affordable and low-
power in comparison to other traditional excitation sources. The excitation is USB
powered, but can easily be battery-powered as well.
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• The design is smartphone-based. Smartphones are widely used, compact and tech-
nologically versatile in relation to cost. They are becoming popular tools for mobile
scientific applications.
The project objectives also require that the relationship between the measured fluores-
cence signal and the inflammatory status of the patient should be evaluated. Furthermore,
the effectiveness of the device should be evaluated in terms of it’s ability to discriminate
between the PPP of healthy individuals and individuals with inflammatory NCDs.
In order to reach these objectives, the prototype was used to test the PPP of six con-
trol, six colorectal cancer (CRC) and three psoriasis (PSO) patients. The fluorescence
intensity measurements of the CRC and PSO sample were, on average, higher than that
of the control samples. An analysis of variance showed a significant difference between
the control and CRC group means, and also between the control and PSO group means.
The evaluation was, however limited by the number of available PPP samples. For more
accurate results, a larger sample size is required.
Even though the results are promising, the control samples had more bound Amy630 than
expected and the difference between the control and inflammatory group means were not
as large as expected. During the evaluation, the presence of background noise due the ex-
citation source, unbound Amy630 fluorescence and PPP autofluroescence was ruled out.
Therefore, the excessive control sample fluorescence brought the amyloid-specificity of the
detected signal into question. It was hypothesised that the Amy630 molecules interact
with other plasma molecules, such as fibrinogen, and undergo conformational changes that
cause them to fluoresce. To test this hypothesis, increasing concentrations of Amy630 was
added to samples of reconstituted normal fibrinogen and LTA-exposed fibrinogen. The
LTA-exposure induces amyloid-formation. The following observations and corresponding
conclusions were made during this investigation:
• Amy630 does fluoresce in the presence of normal fibrinogen. Therefore, the detected
fluorescence signal does not exclusively originate form Amy630 bound to amyloid
fibrin(ogen) structures.
• The fibrinogen concentration in the samples was comparable to that in healthy PPP,
yet the fluorescence was still significantly less than the fluorescence emitted by the
control PPP samples containing the same concentration of Amy630. Therefore,
it was concluded that Amy630 not only interacts with fibrinogen, but with other
plasma molecules as well.
• The fluorescence intensity emitted by the normal fibrinogen samples increased lin-
early with a exponential increase in added Amy630. Although the mechanism of
interaction is unknown, it is suggested that the emission is most likely aggregation-
induced. If the emission was due to binding between the Amy630 and plasma
molecules, one would expect to see a plateau in fluorescence intensity as the Amy630
concentration is increased, due to the decrease in available binding sites.
• The difference between the normal and LTA-exposed sample fluorescence was in-
significant. Although some of the detected fluorescence may still be a results of the
binding between Amy630 and amyloid fibrin(ogen), this fluorescence could not be
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extracted from the background noise and its contribution to the total fluorescence
could not be determined.
• If it is the case that an interaction between the Amy630 and plasma molecules
causes Amy630 aggregation and aggregation-induced fluorescence, an upregulation
in certain plasma-molecules may result in increased fluorescence intensity. Since
the upregulation of certain plasma molecules, like fibrinogen, are indicative of in-
flammation, it makes sense that the inflammatory disease samples produced more
fluorescence than the control samples.
The project objectives have all been met. However, due to the novelty of the physiological
research on which the project is based, as well as the multidisciplinary nature of the
work that had to be done, there is much opportunity for further work and improvement.
Recommendations for further work are discussed next.
5.2 Recommendations
Although the FID is able to detect and quantify the emission from fluorescing Amy630
molecules as required, the unexpected binding and fluorescence behaviour of the Amy630
molecules has brought the significance of the detected signal into question. In order to
gain more insight into the significance of the detected signal, further tests with larger sam-
ple sizes have to be performed. Therefore, more control and inflammatory blood must be
sourced and a well-structured database containing patient information and standardised
test results pertaining to their inflammatory profile must be created.
The interaction between Amy630 and plasma molecules is uncertain. In further work, one
could either attempt to characterize this interaction by doing affinity studies and using
advanced techniques such as nuclear magnetic resonance, or one could explore alternative
amyloid-specific fluorescence markers.
Since the FID is a rough prototype, there is much room for improvement and optimisation
in terms of the structural and optical design. The following suggestions are made:
• The smartphone microscope can be replaced with a more custom optical design that
reduces aberration and has better transmittance.
• The geometric tolerances for accurate optical systems are typically very small.
Therefore, it is important to use high resolution 3D printing for prototyping. The
MakerBot used to print the FID parts is an expensive 3D printer, but leaves much
to be desired in terms of printing quality.
• Alternative methods of sample containment that do not cause sample meniscus
variability can be explored.
Although the FID successfully measures and quantifies fluorescence intensity, additional
image processing strategies should be explored. Recommendations for further work in
terms of the FID software include:
• Although the unprocessed nature of RAW images is desirable, the large file sizes
result in less than desirable processing times. Image processing methods that reduce
file-size, while maintaining the relevant data-integrity must be explored.
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• The use of machine learning techniques to analyse sample images and make diag-
nostic predictions based on structural and spectral information can be investigated.
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